<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://ascptpod.com/wp-content/plugins/seriously-simple-podcasting/templates/feed-stylesheet.xsl"?><rss version="2.0"
	 xmlns:content="http://purl.org/rss/1.0/modules/content/"
	 xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	 xmlns:dc="http://purl.org/dc/elements/1.1/"
	 xmlns:atom="http://www.w3.org/2005/Atom"
	 xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	 xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	 xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0"
	 xmlns:podcast="https://podcastindex.org/namespace/1.0"
	>
		<channel>
		<title>ASCPT Podcast Channel</title>
		<atom:link href="https://ascptpod.com/feed/podcast/ascpt-podcast-channel/" rel="self" type="application/rss+xml"/>
		<link>https://ascptpod.com/series/ascpt-podcast-channel/</link>
		<description>The ASCPT Podcast Channel is the official podcast stream of the American Society for Clinical Pharmacology &amp; Therapeutics (ASCPT). The goal of the channel is to provide further insight into articles published in the ASCPT’s family of journals.</description>
		<lastBuildDate>Fri, 06 Mar 2026 12:00:13 +0000</lastBuildDate>
		<language>en-US</language>
		<copyright>© Wiley</copyright>
		<itunes:subtitle>The official podcast for the ASCPT&#039;s journal family</itunes:subtitle>
		<itunes:author>American Society for Clinical Pharmacology and Therapeutics</itunes:author>
		<itunes:type>episodic</itunes:type>
		<itunes:summary>The ASCPT Podcast Channel is the official podcast stream of the American Society for Clinical Pharmacology &amp; Therapeutics (ASCPT). The goal of the channel is to provide further insight into articles published in the ASCPT’s family of journals.</itunes:summary>
		<itunes:owner>
			<itunes:name>Wiley</itunes:name>
			<itunes:email>bcoughli@wiley.com</itunes:email>
		</itunes:owner>
		<itunes:explicit>false</itunes:explicit>
		<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
			<image>
				<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
				<title>ASCPT Podcast Channel</title>
				<link>https://ascptpod.com/series/ascpt-podcast-channel/</link>
			</image>
		<itunes:category text="Science">
			<itunes:category text="Medicine"></itunes:category>
		</itunes:category>
		<googleplay:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></googleplay:author>
			<googleplay:email>bcoughli@wiley.com</googleplay:email>			<googleplay:description>The ASCPT Podcast Channel is the official podcast stream of the American Society for Clinical Pharmacology &amp; Therapeutics (ASCPT). The goal of the channel is to provide further insight into articles published in the ASCPT’s family of journals.</googleplay:description>
			<googleplay:explicit>No</googleplay:explicit>
			<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
			<podcast:locked owner="bcoughli@wiley.com">yes</podcast:locked>
		<podcast:guid>0b50e55a-f23d-58d0-91cc-3c1b5bdfd08b</podcast:guid>
		
		<!-- podcast_generator="SSP by Castos/3.14.3" Seriously Simple Podcasting plugin for WordPress (https://wordpress.org/plugins/seriously-simple-podcasting/) -->
		<generator>https://wordpress.org/?v=6.9.4</generator>

<item>
	<title>CPT Call for Papers: Understudied Populations</title>
	<link>https://ascptpod.com/podcast/cpt-call-for-papers-understudied-populations/</link>
	<pubDate>Fri, 06 Mar 2026 12:00:13 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">6ed07c35-4166-523a-a81d-d3c7d31af132</guid>
	<description><![CDATA[<p>Working on research focusing on an understudied population? Consider submitting to the CPT themed issue &#8220;<a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28743/CPT-Call-for-Papers-Understudied-Populations__;!!N11eV2iwtfs!qgfvX-f03-EFijJJVyzq0BQbrmvarmBH89bU248vld1cQBjxtfqAMKd59nQSE1W10x_zBdLSTGMmdA$">Advancing Therapeutics for Understudied Patient Groups</a>.&#8221; This episode dives into the call for papers and what aspects of this topic editors are really hoping to see highlighted in submitted research. Submission deadline: June 30, 2026.</p>]]></description>
	<itunes:subtitle><![CDATA[Working on research focusing on an understudied population? Consider submitting to the CPT themed issue &#8220;Advancing Therapeutics for Understudied Patient Groups.&#8221; This episode dives into the call for papers and what aspects of this topic edito]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Working on research focusing on an understudied population? Consider submitting to the CPT themed issue &#8220;<a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28743/CPT-Call-for-Papers-Understudied-Populations__;!!N11eV2iwtfs!qgfvX-f03-EFijJJVyzq0BQbrmvarmBH89bU248vld1cQBjxtfqAMKd59nQSE1W10x_zBdLSTGMmdA$">Advancing Therapeutics for Understudied Patient Groups</a>.&#8221; This episode dives into the call for papers and what aspects of this topic editors are really hoping to see highlighted in submitted research. Submission deadline: June 30, 2026.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/401/cpt-call-for-papers-understudied-populations.mp3" length="17475156" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Working on research focusing on an understudied population? Consider submitting to the CPT themed issue &#8220;Advancing Therapeutics for Understudied Patient Groups.&#8221; This episode dives into the call for papers and what aspects of this topic editors are really hoping to see highlighted in submitted research. Submission deadline: June 30, 2026.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>CPT Call for Papers: Understudied Populations</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:17:20</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Working on research focusing on an understudied population? Consider submitting to the CPT themed issue &#8220;Advancing Therapeutics for Understudied Patient Groups.&#8221; This episode dives into the call for papers and what aspects of this topic editors are really hoping to see highlighted in submitted research. Submission deadline: June 30, 2026.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>CPT Call for Papers: Advances in New Approach Methodologies (NAMs)</title>
	<link>https://ascptpod.com/podcast/cpt-call-for-papers-advances-in-new-approach-methodologies-nams/</link>
	<pubDate>Fri, 27 Feb 2026 20:40:27 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">93d5b312-b085-5a79-8fa3-1c86e97d3c4b</guid>
	<description><![CDATA[<p>Check out the latest <em>Clinical Pharmacology &amp; Therapeutics</em> call for papers on &#8220;Advances in New Approach Methodologies (NAMs): From Bench Development and Validation to Regulatory Adoption.&#8221; The submission deadline is June 1, 2026, so submit your research soon!</p>]]></description>
	<itunes:subtitle><![CDATA[Check out the latest Clinical Pharmacology &amp; Therapeutics call for papers on &#8220;Advances in New Approach Methodologies (NAMs): From Bench Development and Validation to Regulatory Adoption.&#8221; The submission deadline is June 1, 2026, so submit]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Check out the latest <em>Clinical Pharmacology &amp; Therapeutics</em> call for papers on &#8220;Advances in New Approach Methodologies (NAMs): From Bench Development and Validation to Regulatory Adoption.&#8221; The submission deadline is June 1, 2026, so submit your research soon!</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/399/cpt-call-for-papers-advances-in-new-approach-methodologies-nams.mp3" length="10866276" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Check out the latest Clinical Pharmacology &amp; Therapeutics call for papers on &#8220;Advances in New Approach Methodologies (NAMs): From Bench Development and Validation to Regulatory Adoption.&#8221; The submission deadline is June 1, 2026, so submit your research soon!]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>CPT Call for Papers: Advances in New Approach Methodologies (NAMs)</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:11:02</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Check out the latest Clinical Pharmacology &amp; Therapeutics call for papers on &#8220;Advances in New Approach Methodologies (NAMs): From Bench Development and Validation to Regulatory Adoption.&#8221; The submission deadline is June 1, 2026, so submit your research soon!]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>End of an Era: CPT Says Farewell to Piet van der Graaf and Kathy Giacomini</title>
	<link>https://ascptpod.com/podcast/end-of-an-era-cpt-says-farewell-to-piet-van-der-graaf-and-kathy-giacomini/</link>
	<pubDate>Tue, 17 Feb 2026 21:03:54 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">fd1cc4ac-53c3-55da-85c5-db333f629137</guid>
	<description><![CDATA[<p>Listen in as former <em>Clinical Pharmacology &amp; Therapeutics</em> Editor-in-Chief Piet van der Graaf and former Deputy Editor-in-Chief Kathy Giacomini discuss their journeys to clinical pharmacology, ASCPT, and the <em>CPT</em> editorship. They reminisce about mentors and influential people in their lives, challenges and milestones faced at <em>CPT</em>, and how scientific publishing continues to evolve and change.</p>]]></description>
	<itunes:subtitle><![CDATA[Listen in as former Clinical Pharmacology &amp; Therapeutics Editor-in-Chief Piet van der Graaf and former Deputy Editor-in-Chief Kathy Giacomini discuss their journeys to clinical pharmacology, ASCPT, and the CPT editorship. They reminisce about mentors]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Listen in as former <em>Clinical Pharmacology &amp; Therapeutics</em> Editor-in-Chief Piet van der Graaf and former Deputy Editor-in-Chief Kathy Giacomini discuss their journeys to clinical pharmacology, ASCPT, and the <em>CPT</em> editorship. They reminisce about mentors and influential people in their lives, challenges and milestones faced at <em>CPT</em>, and how scientific publishing continues to evolve and change.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/396/end-of-an-era-cpt-says-farewell-to-piet-van-der-graaf-and-kathy-giacomini.mp3" length="33684492" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Listen in as former Clinical Pharmacology &amp; Therapeutics Editor-in-Chief Piet van der Graaf and former Deputy Editor-in-Chief Kathy Giacomini discuss their journeys to clinical pharmacology, ASCPT, and the CPT editorship. They reminisce about mentors and influential people in their lives, challenges and milestones faced at CPT, and how scientific publishing continues to evolve and change.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>End of an Era: CPT Says Farewell to Piet van der Graaf and Kathy Giacomini</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:34:28</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Listen in as former Clinical Pharmacology &amp; Therapeutics Editor-in-Chief Piet van der Graaf and former Deputy Editor-in-Chief Kathy Giacomini discuss their journeys to clinical pharmacology, ASCPT, and the CPT editorship. They reminisce about mentors and influential people in their lives, challenges and milestones faced at CPT, and how scientific publishing continues to evolve and change.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>PSP&#8217;s Latest Themed Issue: Pediatric Rare Diseases</title>
	<link>https://ascptpod.com/podcast/psps-latest-themed-issue-pediatric-rare-diseases/</link>
	<pubDate>Wed, 07 Jan 2026 20:38:03 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">c5701076-c218-5d21-92af-802dba1e8ca8</guid>
	<description><![CDATA[<p><em>CPT: Pharmacometrics &amp; Systems Pharmacology&#8217;s</em> (<em>PSP</em>) 2025 themed issue focused on <a href="https://ascpt.onlinelibrary.wiley.com/toc/21638306/2025/14/11">Pediatric Rare Diseases</a>, which impact more than 25 million people worldwide. Listen as <em>PSP</em> Associate Editors Ping Zhao and Rajat Desikan and Guest Editor Jane Knöchel discuss the conception and planning of this exciting issue as well as articles and topics they found especially interesting and insightful. Interested in publishing with ASCPT? You can find our open Calls for Papers <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Journals/Call-for-Papers__;!!N11eV2iwtfs!pPwioABHvfrqv58P7Y_qBLPLCsgSTkXkeYAKo-cY526cFAuEGtoODQ3gv4fEqurY0FbZ4wfkkoZJ5Q$">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[CPT: Pharmacometrics &amp; Systems Pharmacology&#8217;s (PSP) 2025 themed issue focused on Pediatric Rare Diseases, which impact more than 25 million people worldwide. Listen as PSP Associate Editors Ping Zhao and Rajat Desikan and Guest Editor Jane Knöc]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>CPT: Pharmacometrics &amp; Systems Pharmacology&#8217;s</em> (<em>PSP</em>) 2025 themed issue focused on <a href="https://ascpt.onlinelibrary.wiley.com/toc/21638306/2025/14/11">Pediatric Rare Diseases</a>, which impact more than 25 million people worldwide. Listen as <em>PSP</em> Associate Editors Ping Zhao and Rajat Desikan and Guest Editor Jane Knöchel discuss the conception and planning of this exciting issue as well as articles and topics they found especially interesting and insightful. Interested in publishing with ASCPT? You can find our open Calls for Papers <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Journals/Call-for-Papers__;!!N11eV2iwtfs!pPwioABHvfrqv58P7Y_qBLPLCsgSTkXkeYAKo-cY526cFAuEGtoODQ3gv4fEqurY0FbZ4wfkkoZJ5Q$">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/393/psps-latest-themed-issue-pediatric-rare-diseases.mp3" length="15021660" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[CPT: Pharmacometrics &amp; Systems Pharmacology&#8217;s (PSP) 2025 themed issue focused on Pediatric Rare Diseases, which impact more than 25 million people worldwide. Listen as PSP Associate Editors Ping Zhao and Rajat Desikan and Guest Editor Jane Knöchel discuss the conception and planning of this exciting issue as well as articles and topics they found especially interesting and insightful. Interested in publishing with ASCPT? You can find our open Calls for Papers here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>PSP&#8217;s Latest Themed Issue: Pediatric Rare Diseases</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>00:15:36</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[CPT: Pharmacometrics &amp; Systems Pharmacology&#8217;s (PSP) 2025 themed issue focused on Pediatric Rare Diseases, which impact more than 25 million people worldwide. Listen as PSP Associate Editors Ping Zhao and Rajat Desikan and Guest Editor Jane Knöchel discuss the conception and planning of this exciting issue as well as articles and topics they found especially interesting and insightful. Interested in publishing with ASCPT? You can find our open Calls for Papers here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Clinical and Translational Science Seeks Quantitative Medicine Research</title>
	<link>https://ascptpod.com/podcast/clinical-and-translational-science-seeks-quantitative-medicine-research/</link>
	<pubDate>Thu, 13 Nov 2025 00:00:03 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">40972644-050c-540b-96d4-e28fed1a4edc</guid>
	<description><![CDATA[<p><em>Clinical and Translational Science</em> (<em>CTS</em>) has issued a Call for Papers for a special collection on &#8220;<a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28710/Quantitative-Medicine-Call-for-Papers__;!!N11eV2iwtfs!vjdPhDr-ORDl5TMuJlbKGRpuoPlvV3RuriILsEie7-0_gsc6raEVqRoWfyp7YIEnPtuFi7qGMtsLlQ$">Quantitative Medicine for Drug Discovery, Development, and Clinical Utilization</a>.&#8221; Listen as <em>CTS</em> Associate Editor Lei Zhang and guest editors Chunze Li and Lanfranco Pellesi discuss the need for quantitative research in clinical pharmacology and translational medicine, what types of papers they&#8217;d like to see submitted to the special collection, and how having your paper included in a special collection can boost engagement with your research. <a href="https://urldefense.com/v3/__https:/cts.msubmit.net/__;!!N11eV2iwtfs!vjdPhDr-ORDl5TMuJlbKGRpuoPlvV3RuriILsEie7-0_gsc6raEVqRoWfyp7YIEnPtuFi7rCnZ-KZA$">Submissions</a> for this collection should be received no later than January 31, 2026.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical and Translational Science (CTS) has issued a Call for Papers for a special collection on &#8220;Quantitative Medicine for Drug Discovery, Development, and Clinical Utilization.&#8221; Listen as CTS Associate Editor Lei Zhang and guest editors Ch]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical and Translational Science</em> (<em>CTS</em>) has issued a Call for Papers for a special collection on &#8220;<a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28710/Quantitative-Medicine-Call-for-Papers__;!!N11eV2iwtfs!vjdPhDr-ORDl5TMuJlbKGRpuoPlvV3RuriILsEie7-0_gsc6raEVqRoWfyp7YIEnPtuFi7qGMtsLlQ$">Quantitative Medicine for Drug Discovery, Development, and Clinical Utilization</a>.&#8221; Listen as <em>CTS</em> Associate Editor Lei Zhang and guest editors Chunze Li and Lanfranco Pellesi discuss the need for quantitative research in clinical pharmacology and translational medicine, what types of papers they&#8217;d like to see submitted to the special collection, and how having your paper included in a special collection can boost engagement with your research. <a href="https://urldefense.com/v3/__https:/cts.msubmit.net/__;!!N11eV2iwtfs!vjdPhDr-ORDl5TMuJlbKGRpuoPlvV3RuriILsEie7-0_gsc6raEVqRoWfyp7YIEnPtuFi7rCnZ-KZA$">Submissions</a> for this collection should be received no later than January 31, 2026.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/389/clinical-and-translational-science-seeks-quantitative-medicine-research.mp3" length="10063116" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical and Translational Science (CTS) has issued a Call for Papers for a special collection on &#8220;Quantitative Medicine for Drug Discovery, Development, and Clinical Utilization.&#8221; Listen as CTS Associate Editor Lei Zhang and guest editors Chunze Li and Lanfranco Pellesi discuss the need for quantitative research in clinical pharmacology and translational medicine, what types of papers they&#8217;d like to see submitted to the special collection, and how having your paper included in a special collection can boost engagement with your research. Submissions for this collection should be received no later than January 31, 2026.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>Clinical and Translational Science Seeks Quantitative Medicine Research</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>10:23</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical and Translational Science (CTS) has issued a Call for Papers for a special collection on &#8220;Quantitative Medicine for Drug Discovery, Development, and Clinical Utilization.&#8221; Listen as CTS Associate Editor Lei Zhang and guest editors Chunze Li and Lanfranco Pellesi discuss the need for quantitative research in clinical pharmacology and translational medicine, what types of papers they&#8217;d like to see submitted to the special collection, and how having your paper included in a special collection can boost engagement with your research. Submissions for this collection should be received no later than January 31, 2026.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>CPT Call for Papers: Elevating the Global Impact of Clinical Pharmacology</title>
	<link>https://ascptpod.com/podcast/cpt-call-for-papers-elevating-the-global-impact-of-clinical-pharmacology/</link>
	<pubDate>Wed, 18 Jun 2025 19:56:38 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=384</guid>
	<description><![CDATA[<p>Incoming <em>Clinical Pharmacology &amp; Therapeutics </em>Editor-in-Chief Karen Rowland Yeo is launching a Call for Papers for the May 2026 issue of <em>CPT</em>, which will be titled &#8220; Elevating the Global Impact of Clinical Pharmacology&#8221;. Hear Karen discuss how her childhood and university experiences in South Africa shaped and continue to influence her approach to clinical pharmacology and translational science, her vision for <em>CPT</em>, and focusing on pharmacoequity in her first themed issue.</p>]]></description>
	<itunes:subtitle><![CDATA[Incoming Clinical Pharmacology &amp; Therapeutics Editor-in-Chief Karen Rowland Yeo is launching a Call for Papers for the May 2026 issue of CPT, which will be titled &#8220; Elevating the Global Impact of Clinical Pharmacology&#8221;. Hear Karen discuss]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Incoming <em>Clinical Pharmacology &amp; Therapeutics </em>Editor-in-Chief Karen Rowland Yeo is launching a Call for Papers for the May 2026 issue of <em>CPT</em>, which will be titled &#8220; Elevating the Global Impact of Clinical Pharmacology&#8221;. Hear Karen discuss how her childhood and university experiences in South Africa shaped and continue to influence her approach to clinical pharmacology and translational science, her vision for <em>CPT</em>, and focusing on pharmacoequity in her first themed issue.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/384/cpt-call-for-papers-elevating-the-global-impact-of-clinical-pharmacology.mp3" length="8877228" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Incoming Clinical Pharmacology &amp; Therapeutics Editor-in-Chief Karen Rowland Yeo is launching a Call for Papers for the May 2026 issue of CPT, which will be titled &#8220; Elevating the Global Impact of Clinical Pharmacology&#8221;. Hear Karen discuss how her childhood and university experiences in South Africa shaped and continue to influence her approach to clinical pharmacology and translational science, her vision for CPT, and focusing on pharmacoequity in her first themed issue.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>CPT Call for Papers: Elevating the Global Impact of Clinical Pharmacology</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:52</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Incoming Clinical Pharmacology &amp; Therapeutics Editor-in-Chief Karen Rowland Yeo is launching a Call for Papers for the May 2026 issue of CPT, which will be titled &#8220; Elevating the Global Impact of Clinical Pharmacology&#8221;. Hear Karen discuss how her childhood and university experiences in South Africa shaped and continue to influence her approach to clinical pharmacology and translational science, her vision for CPT, and focusing on pharmacoequity in her first themed issue.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>CTS Call for Papers: Biomarkers</title>
	<link>https://ascptpod.com/podcast/cts-call-for-papers-biomarkers/</link>
	<pubDate>Mon, 19 May 2025 20:37:36 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=381</guid>
	<description><![CDATA[<p>Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as <em>Clinical and Translational Science </em>Associate Editor Sonal Singh and Guest Editor Zachary Taylor discuss the open <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28653/CTS-Call-for-Papers-Biomarkers__;!!N11eV2iwtfs!sE_MqjA0pV9zzDBZ8Tg-cMdcn7eZ0Lxj7f5ltEeCfdmy0lnB3-B7klgFtF6z015RwJRV1EDuTiqi9Q$">Biomarkers Call for Papers</a> and what themes they&#8217;d like to see covered in this upcoming special collection, as well as the deadline for submission.</p>]]></description>
	<itunes:subtitle><![CDATA[Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovat]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as <em>Clinical and Translational Science </em>Associate Editor Sonal Singh and Guest Editor Zachary Taylor discuss the open <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28653/CTS-Call-for-Papers-Biomarkers__;!!N11eV2iwtfs!sE_MqjA0pV9zzDBZ8Tg-cMdcn7eZ0Lxj7f5ltEeCfdmy0lnB3-B7klgFtF6z015RwJRV1EDuTiqi9Q$">Biomarkers Call for Papers</a> and what themes they&#8217;d like to see covered in this upcoming special collection, as well as the deadline for submission.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/381/cts-call-for-papers-biomarkers.mp3" length="8756220" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as Clinical and Translational Science Associate Editor Sonal Singh and Guest Editor Zachary Taylor discuss the open Biomarkers Call for Papers and what themes they&#8217;d like to see covered in this upcoming special collection, as well as the deadline for submission.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>CTS Call for Papers: Biomarkers</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:39</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Biomarkers have transformed the landscape of clinical and translational sciences and are accelerating the progress towards targeted and precision medicine. Breakthrough technological advancement coupled with novel data analysis methods is driving innovations in biomarker identification and validation and is increasingly making biomarkers crucial for drug development and improving patient outcomes. Listen as Clinical and Translational Science Associate Editor Sonal Singh and Guest Editor Zachary Taylor discuss the open Biomarkers Call for Papers and what themes they&#8217;d like to see covered in this upcoming special collection, as well as the deadline for submission.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Bench to Budget: CPT&#8217;s Latest Themed Issue</title>
	<link>https://ascptpod.com/podcast/bench-to-budget-cpts-latest-themed-issue/</link>
	<pubDate>Wed, 30 Apr 2025 23:25:17 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=378</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics </em>Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2025/117/4">CPT&#8217;s latest themed issue</a>, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field developing in the future. Listen to their conversation, and then check out this important issue!</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT&#8217;s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Lea]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics </em>Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2025/117/4">CPT&#8217;s latest themed issue</a>, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field developing in the future. Listen to their conversation, and then check out this important issue!</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/378/bench-to-budget-cpts-latest-themed-issue.mp3" length="14336110" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT&#8217;s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field developing in the future. Listen to their conversation, and then check out this important issue!]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>Bench to Budget: CPT&#8217;s Latest Themed Issue</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>16:38</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics Associate Editor Rebecca Miksad and Guest Editor Sebastian Schneeweiss stop by clinpharmpod to discuss CPT&#8217;s latest themed issue, which focuses on pharmacoepidemiology and the concept of bench to budget. Learn about the evolution of bench to budget, which articles in the issue caught their eye, and how they see this field developing in the future. Listen to their conversation, and then check out this important issue!]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>CTS AI/ML</title>
	<link>https://ascptpod.com/podcast/cts-ai-ml/</link>
	<pubDate>Thu, 10 Apr 2025 11:00:10 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=374</guid>
	<description><![CDATA[<p><em>Clinical and Translational Science</em> Associate Editor Mohamed Shahin sits down to discuss <em>CTS&#8217;</em>s latest <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.ai-machine-learning">special collection on artificial intelligence and machine learning</a>. He delves into the decision-making process in choosing this theme, trends in AI/ML research that can be seen in the collection, and where he sees this field of research going next. If you&#8217;re interested in seeing what other calls for papers <em>CTS </em>has open, click <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Journals/Call-for-Papers__;!!N11eV2iwtfs!ocVyS0S_5L1th3U-iEznZUtgFRfJ022u7X05Eqmz1EppG2JKBUKt_XccsjAVtRytBhqDjSfur-nzcg$">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical and Translational Science Associate Editor Mohamed Shahin sits down to discuss CTS&#8217;s latest special collection on artificial intelligence and machine learning. He delves into the decision-making process in choosing this theme, trends in AI]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical and Translational Science</em> Associate Editor Mohamed Shahin sits down to discuss <em>CTS&#8217;</em>s latest <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.ai-machine-learning">special collection on artificial intelligence and machine learning</a>. He delves into the decision-making process in choosing this theme, trends in AI/ML research that can be seen in the collection, and where he sees this field of research going next. If you&#8217;re interested in seeing what other calls for papers <em>CTS </em>has open, click <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Journals/Call-for-Papers__;!!N11eV2iwtfs!ocVyS0S_5L1th3U-iEznZUtgFRfJ022u7X05Eqmz1EppG2JKBUKt_XccsjAVtRytBhqDjSfur-nzcg$">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/374/cts-ai-ml.mp3" length="15863076" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical and Translational Science Associate Editor Mohamed Shahin sits down to discuss CTS&#8217;s latest special collection on artificial intelligence and machine learning. He delves into the decision-making process in choosing this theme, trends in AI/ML research that can be seen in the collection, and where he sees this field of research going next. If you&#8217;re interested in seeing what other calls for papers CTS has open, click here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>CTS AI/ML</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>15:05</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical and Translational Science Associate Editor Mohamed Shahin sits down to discuss CTS&#8217;s latest special collection on artificial intelligence and machine learning. He delves into the decision-making process in choosing this theme, trends in AI/ML research that can be seen in the collection, and where he sees this field of research going next. If you&#8217;re interested in seeing what other calls for papers CTS has open, click here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Wiley OA Agreements     </title>
	<link>https://ascptpod.com/podcast/wiley-oa-agreements/</link>
	<pubDate>Thu, 27 Mar 2025 11:00:33 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=372</guid>
	<description><![CDATA[<p>Wiley&#8217;s Sarah Whalen stops by to discuss the publisher&#8217;s Transformational Agreements for Open Access publishing. She shares how to find out if your Open Access fees might be covered under an existing transformational agreement, the benefits of Open Access publishing, how to navigate licensing agreements, and more. Sarah specifically mentions <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__authorservices.wiley.com_home.html&amp;d=DwMGaQ&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=Tbr551gnSveyr8NK9cJjWxdw8AT6U7ESUFKnOe0j0rs&amp;m=OVZQf4p27d0zZD9Zuu7qAhVaWZ_apqW3DVM-sk3UlZDHvBS5nG6YuNPepqPUB-nD&amp;s=6zDcFUkiVzjlTG23qVxzP87X8zIyPh-Z7bva6a1YdF0&amp;e=" data-auth="NotApplicable" data-linkindex="2" data-olk-copy-source="MessageBody">Wiley Author Services</a> and the Transformational Agreement <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__m.info.wiley.com_webApp_openaccess-3Futm-5Fsource-3DAS-26utm-5Fmedium-3Dgif-26utm-5Fcampaign-3DRM-2DDG-2DJB-2DWOAA-2DAuthors-2D90755&amp;d=DwMGaQ&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=Tbr551gnSveyr8NK9cJjWxdw8AT6U7ESUFKnOe0j0rs&amp;m=OVZQf4p27d0zZD9Zuu7qAhVaWZ_apqW3DVM-sk3UlZDHvBS5nG6YuNPepqPUB-nD&amp;s=itK8oPzCUN6tL4mgf63dD4-O32blDhsPlqt2XZRbKcw&amp;e=" data-olk-copy-source="MessageBody" data-linkindex="3" data-auth="NotApplicable">Eligibility Checker</a>, so be sure to check out those resources after you&#8217;ve listened to this episode.</p>]]></description>
	<itunes:subtitle><![CDATA[Wiley&#8217;s Sarah Whalen stops by to discuss the publisher&#8217;s Transformational Agreements for Open Access publishing. She shares how to find out if your Open Access fees might be covered under an existing transformational agreement, the benefits o]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Wiley&#8217;s Sarah Whalen stops by to discuss the publisher&#8217;s Transformational Agreements for Open Access publishing. She shares how to find out if your Open Access fees might be covered under an existing transformational agreement, the benefits of Open Access publishing, how to navigate licensing agreements, and more. Sarah specifically mentions <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__authorservices.wiley.com_home.html&amp;d=DwMGaQ&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=Tbr551gnSveyr8NK9cJjWxdw8AT6U7ESUFKnOe0j0rs&amp;m=OVZQf4p27d0zZD9Zuu7qAhVaWZ_apqW3DVM-sk3UlZDHvBS5nG6YuNPepqPUB-nD&amp;s=6zDcFUkiVzjlTG23qVxzP87X8zIyPh-Z7bva6a1YdF0&amp;e=" data-auth="NotApplicable" data-linkindex="2" data-olk-copy-source="MessageBody">Wiley Author Services</a> and the Transformational Agreement <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__m.info.wiley.com_webApp_openaccess-3Futm-5Fsource-3DAS-26utm-5Fmedium-3Dgif-26utm-5Fcampaign-3DRM-2DDG-2DJB-2DWOAA-2DAuthors-2D90755&amp;d=DwMGaQ&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=Tbr551gnSveyr8NK9cJjWxdw8AT6U7ESUFKnOe0j0rs&amp;m=OVZQf4p27d0zZD9Zuu7qAhVaWZ_apqW3DVM-sk3UlZDHvBS5nG6YuNPepqPUB-nD&amp;s=itK8oPzCUN6tL4mgf63dD4-O32blDhsPlqt2XZRbKcw&amp;e=" data-olk-copy-source="MessageBody" data-linkindex="3" data-auth="NotApplicable">Eligibility Checker</a>, so be sure to check out those resources after you&#8217;ve listened to this episode.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/372/wiley-oa-agreements.mp3" length="9172692" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Wiley&#8217;s Sarah Whalen stops by to discuss the publisher&#8217;s Transformational Agreements for Open Access publishing. She shares how to find out if your Open Access fees might be covered under an existing transformational agreement, the benefits of Open Access publishing, how to navigate licensing agreements, and more. Sarah specifically mentions Wiley Author Services and the Transformational Agreement Eligibility Checker, so be sure to check out those resources after you&#8217;ve listened to this episode.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>Wiley OA Agreements     </title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:33</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Wiley&#8217;s Sarah Whalen stops by to discuss the publisher&#8217;s Transformational Agreements for Open Access publishing. She shares how to find out if your Open Access fees might be covered under an existing transformational agreement, the benefits of Open Access publishing, how to navigate licensing agreements, and more. Sarah specifically mentions Wiley Author Services and the Transformational Agreement Eligibility Checker, so be sure to check out those resources after you&#8217;ve listened to this episode.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>CTS Special Collection on Diversity, Equity, and Inclusion</title>
	<link>https://ascptpod.com/podcast/cts-special-collection-on-diversity-equity-and-inclusion/</link>
	<pubDate>Fri, 07 Mar 2025 19:47:41 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=369</guid>
	<description><![CDATA[<p><em>Clinical and Translational Science</em> Editor-in-Chief John Wagner and Associate Editor Elvin Price stop by the podcast to discuss <em>CTS</em>&#8216;s latest special collection on <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.DEI">Diversity, Equity, and Inclusion</a>. They share their thoughts on the importance of DEI in clinical pharmacology and translational science as well as trends found in the collection and where they see research headed in the future. They also discuss other opportunities to submit your research to <em>CTS</em>, and you can read about all these open calls for papers <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Journals/Call-for-Papers__;!!N11eV2iwtfs!o71yF3nd9pS38u3QVMXglv1lLywwB3_LN9wqPe9olfbhM500RYsUhtL2EP3-O7Q_YnJ6NS1jD7V80A$">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical and Translational Science Editor-in-Chief John Wagner and Associate Editor Elvin Price stop by the podcast to discuss CTS&#8216;s latest special collection on Diversity, Equity, and Inclusion. They share their thoughts on the importance of DEI i]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical and Translational Science</em> Editor-in-Chief John Wagner and Associate Editor Elvin Price stop by the podcast to discuss <em>CTS</em>&#8216;s latest special collection on <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.DEI">Diversity, Equity, and Inclusion</a>. They share their thoughts on the importance of DEI in clinical pharmacology and translational science as well as trends found in the collection and where they see research headed in the future. They also discuss other opportunities to submit your research to <em>CTS</em>, and you can read about all these open calls for papers <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Journals/Call-for-Papers__;!!N11eV2iwtfs!o71yF3nd9pS38u3QVMXglv1lLywwB3_LN9wqPe9olfbhM500RYsUhtL2EP3-O7Q_YnJ6NS1jD7V80A$">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/369/cts-special-collection-on-diversity-equity-and-inclusion.mp3" length="11322060" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical and Translational Science Editor-in-Chief John Wagner and Associate Editor Elvin Price stop by the podcast to discuss CTS&#8216;s latest special collection on Diversity, Equity, and Inclusion. They share their thoughts on the importance of DEI in clinical pharmacology and translational science as well as trends found in the collection and where they see research headed in the future. They also discuss other opportunities to submit your research to CTS, and you can read about all these open calls for papers here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>CTS Special Collection on Diversity, Equity, and Inclusion</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>12:13</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical and Translational Science Editor-in-Chief John Wagner and Associate Editor Elvin Price stop by the podcast to discuss CTS&#8216;s latest special collection on Diversity, Equity, and Inclusion. They share their thoughts on the importance of DEI in clinical pharmacology and translational science as well as trends found in the collection and where they see research headed in the future. They also discuss other opportunities to submit your research to CTS, and you can read about all these open calls for papers here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>PSP Launches MBMA Call for Papers   </title>
	<link>https://ascptpod.com/podcast/psp-launches-mbma-call-for-papers/</link>
	<pubDate>Wed, 19 Feb 2025 12:00:51 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=366</guid>
	<description><![CDATA[<p>Led by <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em> Associate Editor Dr. Jonathan French, <em>PSP</em> has launched a call for papers for &#8220;<a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleID/28642__;!!N11eV2iwtfs!piTEAhNcKcyYrPUNB9J5zDEaPixgzXHPU-GNP99tx_2z19TS6JM3URaWoPCs_HlINJbjZHf-XOsTtA$">Applications and Innovations in Model-Based Meta-Analysis (MBMA)</a>.&#8221; Join host Alaina Webster, as she sits down with Dr. French, <em>PSP</em> Editor-in-Training Dr. Jiawei Zhou, and guest editors Drs. Phyllis Chan, Monica Simeoni, and Matt Zierhut to discuss the thought processes around this theme, manuscript types, and potential areas of interest. All submissions are due by June 15, 2025. If you have questions about the theme or submission process, please contact ASCPT Managing Editor Alethea Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Led by CPT: Pharmacometrics &amp; Systems Pharmacology Associate Editor Dr. Jonathan French, PSP has launched a call for papers for &#8220;Applications and Innovations in Model-Based Meta-Analysis (MBMA).&#8221; Join host Alaina Webster, as she sits down]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Led by <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em> Associate Editor Dr. Jonathan French, <em>PSP</em> has launched a call for papers for &#8220;<a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleID/28642__;!!N11eV2iwtfs!piTEAhNcKcyYrPUNB9J5zDEaPixgzXHPU-GNP99tx_2z19TS6JM3URaWoPCs_HlINJbjZHf-XOsTtA$">Applications and Innovations in Model-Based Meta-Analysis (MBMA)</a>.&#8221; Join host Alaina Webster, as she sits down with Dr. French, <em>PSP</em> Editor-in-Training Dr. Jiawei Zhou, and guest editors Drs. Phyllis Chan, Monica Simeoni, and Matt Zierhut to discuss the thought processes around this theme, manuscript types, and potential areas of interest. All submissions are due by June 15, 2025. If you have questions about the theme or submission process, please contact ASCPT Managing Editor Alethea Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/366/psp-launches-mbma-call-for-papers.mp3" length="11442742" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Led by CPT: Pharmacometrics &amp; Systems Pharmacology Associate Editor Dr. Jonathan French, PSP has launched a call for papers for &#8220;Applications and Innovations in Model-Based Meta-Analysis (MBMA).&#8221; Join host Alaina Webster, as she sits down with Dr. French, PSP Editor-in-Training Dr. Jiawei Zhou, and guest editors Drs. Phyllis Chan, Monica Simeoni, and Matt Zierhut to discuss the thought processes around this theme, manuscript types, and potential areas of interest. All submissions are due by June 15, 2025. If you have questions about the theme or submission process, please contact ASCPT Managing Editor Alethea Gerding at alethea@ascpt.org.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>PSP Launches MBMA Call for Papers   </title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>15:00</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Led by CPT: Pharmacometrics &amp; Systems Pharmacology Associate Editor Dr. Jonathan French, PSP has launched a call for papers for &#8220;Applications and Innovations in Model-Based Meta-Analysis (MBMA).&#8221; Join host Alaina Webster, as she sits down with Dr. French, PSP Editor-in-Training Dr. Jiawei Zhou, and guest editors Drs. Phyllis Chan, Monica Simeoni, and Matt Zierhut to discuss the thought processes around this theme, manuscript types, and potential areas of interest. All submissions are due by June 15, 2025. If you have questions about the theme or submission process, please contact ASCPT Managing Editor Alethea Gerding at alethea@ascpt.org.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>CPT Call for Papers: Innovations in Clinical Pharmacology and Therapeutics.</title>
	<link>https://ascptpod.com/podcast/cpt-call-for-papers-innovations-in-clinical-pharmacology-and-therapeutics/</link>
	<pubDate>Wed, 05 Feb 2025 13:00:51 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=363</guid>
	<description><![CDATA[<p>Clinical Pharmacology &amp; Therapeutics Associate Editors Drs. Amita Joshi and Karthik Venkatakrishnan join CPT Editor-in-Chief Dr. Piet van der Graaf to discuss the journal&#8217;s latest Call for Papers:  <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28644/CPT-Call-For-Papers-Innovations__;!!N11eV2iwtfs!uJW7ea6XFZuCqhdSjq3XoSRGANP99bL1go1WDF0-tZ8D-kLalS0-zztTl98ElldDCyAF_GTBzgRiig$">Innovations in Clinical Pharmacology and Therapeutics</a>. The editors discuss choosing to focus on clinical innovations in 2025, manuscript types and topics, and other exciting upcoming research from <em>CPT</em>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics Associate Editors Drs. Amita Joshi and Karthik Venkatakrishnan join CPT Editor-in-Chief Dr. Piet van der Graaf to discuss the journal&#8217;s latest Call for Papers:  Innovations in Clinical Pharmacology and Thera]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Clinical Pharmacology &amp; Therapeutics Associate Editors Drs. Amita Joshi and Karthik Venkatakrishnan join CPT Editor-in-Chief Dr. Piet van der Graaf to discuss the journal&#8217;s latest Call for Papers:  <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28644/CPT-Call-For-Papers-Innovations__;!!N11eV2iwtfs!uJW7ea6XFZuCqhdSjq3XoSRGANP99bL1go1WDF0-tZ8D-kLalS0-zztTl98ElldDCyAF_GTBzgRiig$">Innovations in Clinical Pharmacology and Therapeutics</a>. The editors discuss choosing to focus on clinical innovations in 2025, manuscript types and topics, and other exciting upcoming research from <em>CPT</em>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/363/cpt-call-for-papers-innovations-in-clinical-pharmacology-and-therapeutics.mp3" length="9212518" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics Associate Editors Drs. Amita Joshi and Karthik Venkatakrishnan join CPT Editor-in-Chief Dr. Piet van der Graaf to discuss the journal&#8217;s latest Call for Papers:  Innovations in Clinical Pharmacology and Therapeutics. The editors discuss choosing to focus on clinical innovations in 2025, manuscript types and topics, and other exciting upcoming research from CPT.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png</url>
		<title>CPT Call for Papers: Innovations in Clinical Pharmacology and Therapeutics.</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:42</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics Associate Editors Drs. Amita Joshi and Karthik Venkatakrishnan join CPT Editor-in-Chief Dr. Piet van der Graaf to discuss the journal&#8217;s latest Call for Papers:  Innovations in Clinical Pharmacology and Therapeutics. The editors discuss choosing to focus on clinical innovations in 2025, manuscript types and topics, and other exciting upcoming research from CPT.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2024/12/ASCPT-Podcast-Channel-Logo.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Wrap up 2024 with PSP&#8217;s Pregnancy and Lactation Themed Issue!</title>
	<link>https://ascptpod.com/podcast/wrap-up-2024-with-psps-pregnancy-and-lactation-themed-issue/</link>
	<pubDate>Thu, 19 Dec 2024 18:52:05 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=358</guid>
	<description><![CDATA[<p>Check out the latest episode of PSPod in which Drs. Karen Rowland-Yeo, Priya Jayachandran, Jane Knochel, and Brian Cicacli chat about <em>Pharmacometrics &amp; Systems Pharmacology&#8217;s </em>latest themed issue: <a href="https://ascpt.onlinelibrary.wiley.com/toc/21638306/2024/13/11">Pregnancy/Lactation</a>. They share their thoughts on choosing this theme, how they hope this research will move clinical pharmacology and translational science forward, and which papers caught their eye and sparked their interest.</p>]]></description>
	<itunes:subtitle><![CDATA[Check out the latest episode of PSPod in which Drs. Karen Rowland-Yeo, Priya Jayachandran, Jane Knochel, and Brian Cicacli chat about Pharmacometrics &amp; Systems Pharmacology&#8217;s latest themed issue: Pregnancy/Lactation. They share their thoughts o]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Check out the latest episode of PSPod in which Drs. Karen Rowland-Yeo, Priya Jayachandran, Jane Knochel, and Brian Cicacli chat about <em>Pharmacometrics &amp; Systems Pharmacology&#8217;s </em>latest themed issue: <a href="https://ascpt.onlinelibrary.wiley.com/toc/21638306/2024/13/11">Pregnancy/Lactation</a>. They share their thoughts on choosing this theme, how they hope this research will move clinical pharmacology and translational science forward, and which papers caught their eye and sparked their interest.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/358/wrap-up-2024-with-psps-pregnancy-and-lactation-themed-issue.mp3" length="15884398" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Check out the latest episode of PSPod in which Drs. Karen Rowland-Yeo, Priya Jayachandran, Jane Knochel, and Brian Cicacli chat about Pharmacometrics &amp; Systems Pharmacology&#8217;s latest themed issue: Pregnancy/Lactation. They share their thoughts on choosing this theme, how they hope this research will move clinical pharmacology and translational science forward, and which papers caught their eye and sparked their interest.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Wrap up 2024 with PSP&#8217;s Pregnancy and Lactation Themed Issue!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>17:45</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Check out the latest episode of PSPod in which Drs. Karen Rowland-Yeo, Priya Jayachandran, Jane Knochel, and Brian Cicacli chat about Pharmacometrics &amp; Systems Pharmacology&#8217;s latest themed issue: Pregnancy/Lactation. They share their thoughts on choosing this theme, how they hope this research will move clinical pharmacology and translational science forward, and which papers caught their eye and sparked their interest.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>PSP Call for Papers: Model-Based Innovations in Pediatric Rare Disease</title>
	<link>https://ascptpod.com/podcast/psp-call-for-papers-model-based-innovations-in-pediatric-rare-disease/</link>
	<pubDate>Mon, 18 Nov 2024 19:43:17 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=353</guid>
	<description><![CDATA[<p>Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;<a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28627/PSP-Call-for-Papers-Model-Based-Innovations-in-Pediatric-Rare-Disease__;!!N11eV2iwtfs!ri1dAijWgA_RjcnvtNiSgQxgllqfzJaOgWeakAz8aftUb6ztoq8LSqcqkKFWAnc8zvBAwPGP8zrzcg$">Model-Based Innovations in Pediatric Rare Diseas</a>e.&#8221; Find out why the PSP Editorial Team chose to highlight this topic in 2025, what types of submissions they&#8217;re hoping to receive, why publishing in a themed issue can boost the profile of your research, and more!</p>]]></description>
	<itunes:subtitle><![CDATA[Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;Model-Based Innovations in Pediatric Rare Disease.&#8221; Find out why the PSP Edit]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;<a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28627/PSP-Call-for-Papers-Model-Based-Innovations-in-Pediatric-Rare-Disease__;!!N11eV2iwtfs!ri1dAijWgA_RjcnvtNiSgQxgllqfzJaOgWeakAz8aftUb6ztoq8LSqcqkKFWAnc8zvBAwPGP8zrzcg$">Model-Based Innovations in Pediatric Rare Diseas</a>e.&#8221; Find out why the PSP Editorial Team chose to highlight this topic in 2025, what types of submissions they&#8217;re hoping to receive, why publishing in a themed issue can boost the profile of your research, and more!</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/353/psp-call-for-papers-model-based-innovations-in-pediatric-rare-disease.mp3" length="7111990" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;Model-Based Innovations in Pediatric Rare Disease.&#8221; Find out why the PSP Editorial Team chose to highlight this topic in 2025, what types of submissions they&#8217;re hoping to receive, why publishing in a themed issue can boost the profile of your research, and more!]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>PSP Call for Papers: Model-Based Innovations in Pediatric Rare Disease</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:53</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Join PSP Associate Editors Ping Zhao and Rajat Desikan as well as former Editor-in-Training Jane Knöchel as they discuss the journal&#8217;s latest Call for Papers &#8220;Model-Based Innovations in Pediatric Rare Disease.&#8221; Find out why the PSP Editorial Team chose to highlight this topic in 2025, what types of submissions they&#8217;re hoping to receive, why publishing in a themed issue can boost the profile of your research, and more!]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Check Out CPT’s Latest Themed Issue &#8220;Getting the Dose Right&#8221;!</title>
	<link>https://ascptpod.com/podcast/check-out-cpts-latest-themed-issue-getting-the-dose-right/</link>
	<pubDate>Wed, 30 Oct 2024 20:05:30 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=350</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics </em>Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2024/116/3">the latest themed issue from CPT</a>, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Editorial Team conceived this theme, what areas of study are highlighted in the issue, and how this theme ties into overarching trends and themes in clinical pharmacology and translational science.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss the latest themed issue from CPT, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Ed]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics </em>Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2024/116/3">the latest themed issue from CPT</a>, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Editorial Team conceived this theme, what areas of study are highlighted in the issue, and how this theme ties into overarching trends and themes in clinical pharmacology and translational science.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/350/check-out-cpts-latest-themed-issue-getting-the-dose-right.mp3" length="16200430" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss the latest themed issue from CPT, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Editorial Team conceived this theme, what areas of study are highlighted in the issue, and how this theme ties into overarching trends and themes in clinical pharmacology and translational science.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Check Out CPT’s Latest Themed Issue &#8220;Getting the Dose Right&#8221;!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>20:19</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics Editors Karthik Venkatakrishnan, Iris Minichmayr, Richard Peck, and Piet van der Graaf stop by clinpharmpod to discuss the latest themed issue from CPT, &#8220;Getting the Dosage Right.&#8221; Learn how the CPT Editorial Team conceived this theme, what areas of study are highlighted in the issue, and how this theme ties into overarching trends and themes in clinical pharmacology and translational science.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Bench-to-Budget: CPT Seeks Pharmacoepidemiology-Themed Research</title>
	<link>https://ascptpod.com/podcast/bench-to-budget-cpt-seeks-pharmacoepidemiology-themed-research/</link>
	<pubDate>Wed, 31 Jul 2024 19:45:51 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=345</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched a <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleID/28590__;!!N11eV2iwtfs!u-2HrAaw5XwHHtuahZxK7mfKx_fo3wC7EN6dgQ1uYkJ09RSiiUPC5-y--UBeLoffXsmM4B1DIpmoLg$">Call for Papers</a> for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.&#8221; Join host Alaina Webster as she welcomes <em>CPT</em> Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Rebecca Miksad, and Guest Editor Dr. Sebastian Schneeweiss to discuss the relevance of this theme in today&#8217;s clin pharm landscape as well as what types of submissions they&#8217;d most like to receive. If you have questions about submitting for this pharmacoepidemiology-themed issue, please contact Deputy Managing Editor Alaina Webster at <a href="mailto:alaina@ascpt.org">alaina@ascpt.org</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency a]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched a <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleID/28590__;!!N11eV2iwtfs!u-2HrAaw5XwHHtuahZxK7mfKx_fo3wC7EN6dgQ1uYkJ09RSiiUPC5-y--UBeLoffXsmM4B1DIpmoLg$">Call for Papers</a> for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.&#8221; Join host Alaina Webster as she welcomes <em>CPT</em> Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Rebecca Miksad, and Guest Editor Dr. Sebastian Schneeweiss to discuss the relevance of this theme in today&#8217;s clin pharm landscape as well as what types of submissions they&#8217;d most like to receive. If you have questions about submitting for this pharmacoepidemiology-themed issue, please contact Deputy Managing Editor Alaina Webster at <a href="mailto:alaina@ascpt.org">alaina@ascpt.org</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/345/bench-to-budget-cpt-seeks-pharmacoepidemiology-themed-research.mp3" length="10662430" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.&#8221; Join host Alaina Webster as she welcomes CPT Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Rebecca Miksad, and Guest Editor Dr. Sebastian Schneeweiss to discuss the relevance of this theme in today&#8217;s clin pharm landscape as well as what types of submissions they&#8217;d most like to receive. If you have questions about submitting for this pharmacoepidemiology-themed issue, please contact Deputy Managing Editor Alaina Webster at alaina@ascpt.org.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Bench-to-Budget: CPT Seeks Pharmacoepidemiology-Themed Research</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>13:41</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its April 2025 themed issue centering on pharmacoepidemiology, titled &#8220;Bench to Budget: Streamlining the Full Spectrum of Evidence Integration to Enhance Efficiency and Impact of Drug-Development and Patient Access.&#8221; Join host Alaina Webster as she welcomes CPT Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Rebecca Miksad, and Guest Editor Dr. Sebastian Schneeweiss to discuss the relevance of this theme in today&#8217;s clin pharm landscape as well as what types of submissions they&#8217;d most like to receive. If you have questions about submitting for this pharmacoepidemiology-themed issue, please contact Deputy Managing Editor Alaina Webster at alaina@ascpt.org.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Call for Papers: DEI in Clinical and Translational Science</title>
	<link>https://ascptpod.com/podcast/call-for-papers-dei-in-clinical-and-translational-science/</link>
	<pubDate>Wed, 17 Jul 2024 16:22:35 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=339</guid>
	<description><![CDATA[<p><em>Clinical and Translational Science</em> (<em>CTS</em>) has launched a <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28589/CTS-Call-for-Papers-Diversity-Equity-and-Inclusion-DEI__;!!N11eV2iwtfs!rZbecZR1JrE9EH__uXwpN1pYd4r5pkectLLaXnDnQB3vklbV5p8vTGO9md_TCBx0l14CdD08we1S9Q$">Call for Papers</a> for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webster as she welcomes <em>CTS</em> Associate Editor Dr. Elvin Price to discuss types of submissions the journal would most like to receive as well as why submitting to a special collection could be a great visibility booster for your paper! If you have questions about submitting for this DEI collection, please contact Managing Editor Alethea Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>. All submission are due no later than December 31, 2024.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webste]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical and Translational Science</em> (<em>CTS</em>) has launched a <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28589/CTS-Call-for-Papers-Diversity-Equity-and-Inclusion-DEI__;!!N11eV2iwtfs!rZbecZR1JrE9EH__uXwpN1pYd4r5pkectLLaXnDnQB3vklbV5p8vTGO9md_TCBx0l14CdD08we1S9Q$">Call for Papers</a> for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webster as she welcomes <em>CTS</em> Associate Editor Dr. Elvin Price to discuss types of submissions the journal would most like to receive as well as why submitting to a special collection could be a great visibility booster for your paper! If you have questions about submitting for this DEI collection, please contact Managing Editor Alethea Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>. All submission are due no later than December 31, 2024.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/339/call-for-papers-dei-in-clinical-and-translational-science.mp3" length="11473486" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webster as she welcomes CTS Associate Editor Dr. Elvin Price to discuss types of submissions the journal would most like to receive as well as why submitting to a special collection could be a great visibility booster for your paper! If you have questions about submitting for this DEI collection, please contact Managing Editor Alethea Gerding at alethea@ascpt.org. All submission are due no later than December 31, 2024.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Call for Papers: DEI in Clinical and Translational Science</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>15:36</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its third special collection, which will focus on diversity, equity, and inclusion (DEI) as it applies to clinical pharmacology and translational science. Join host Alaina Webster as she welcomes CTS Associate Editor Dr. Elvin Price to discuss types of submissions the journal would most like to receive as well as why submitting to a special collection could be a great visibility booster for your paper! If you have questions about submitting for this DEI collection, please contact Managing Editor Alethea Gerding at alethea@ascpt.org. All submission are due no later than December 31, 2024.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Check Out CTS’s Special Collection of Real-World Evidence/Real-World Data Research!</title>
	<link>https://ascptpod.com/podcast/check-out-ctss-special-collection-of-real-world-evidence-real-world-data-research/</link>
	<pubDate>Mon, 24 Jun 2024 22:31:52 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=336</guid>
	<description><![CDATA[<p><em>Clinical and Translational Science</em> Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.RealWorld">Real-World Evidence and Real-World Data</a>, and is capped off by a great <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13835">Editorial</a> contribution from Paulien. Learn more about the thought process behind this collection and what insights you might learn from reading the papers within it!</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical and Translational Science Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on Real-World Evidence and Real-World Data, and is capped]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical and Translational Science</em> Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.RealWorld">Real-World Evidence and Real-World Data</a>, and is capped off by a great <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13835">Editorial</a> contribution from Paulien. Learn more about the thought process behind this collection and what insights you might learn from reading the papers within it!</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/336/check-out-ctss-special-collection-of-real-world-evidence-real-world-data-research.mp3" length="5766862" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical and Translational Science Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on Real-World Evidence and Real-World Data, and is capped off by a great Editorial contribution from Paulien. Learn more about the thought process behind this collection and what insights you might learn from reading the papers within it!]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Check Out CTS’s Special Collection of Real-World Evidence/Real-World Data Research!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>7:28</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical and Translational Science Associate Editor Paulien Ravenstijn joins host Alaina Webster to talk about the papers included in its first Special Collection. This exciting collection focuses on Real-World Evidence and Real-World Data, and is capped off by a great Editorial contribution from Paulien. Learn more about the thought process behind this collection and what insights you might learn from reading the papers within it!]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Learn More About ASCPT&#8217;s Editors-in-Training Program</title>
	<link>https://ascptpod.com/podcast/learn-more-about-ascpts-editors-in-training-program/</link>
	<pubDate>Wed, 19 Jun 2024 03:56:48 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=333</guid>
	<description><![CDATA[<p>Interested in learning more about the ASCPT Journal Family’s <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Journals/Editors-in-Training__;!!N11eV2iwtfs!tGwrEoKdtK_fagoGF3CYZ2nudcz7ujnCJzM8mFWk0u9pHkLrVF7l9DeijoABmME_xgkbOfJmsAtAhA$">Editor-in-Training (EIT) program</a>? Listen as current EITs Drs. <a href="https://urldefense.com/v3/__https:/www.linkedin.com/in/jane-kn**Achel-2a060412b/__;w7Y!!N11eV2iwtfs!tGwrEoKdtK_fagoGF3CYZ2nudcz7ujnCJzM8mFWk0u9pHkLrVF7l9DeijoABmME_xgkbOfJkeY3wgw$">Jane Knöchel</a> and <a href="https://urldefense.com/v3/__https:/www.linkedin.com/in/zltaylor16/__;!!N11eV2iwtfs!tGwrEoKdtK_fagoGF3CYZ2nudcz7ujnCJzM8mFWk0u9pHkLrVF7l9DeijoABmME_xgkbOfIPFgxL1A$">Zachary Taylor</a>, along with former EIT and current <em>Clinical and Translational Science </em>Associate Editor Dr. <a href="https://urldefense.com/v3/__https:/www.linkedin.com/in/brian-ferslew-41b6a3bb/__;!!N11eV2iwtfs!tGwrEoKdtK_fagoGF3CYZ2nudcz7ujnCJzM8mFWk0u9pHkLrVF7l9DeijoABmME_xgkbOfJdKkL-KA$">Brian Ferslew</a>, share their experiences with the program. Applications for the 6th EIT cohort are being accepted through June 20, 2024. If you have any questions about the program or applying, please contact Deputy Managing Editor Alaina Webster at <a href="mailto:alaina@ascpt.org">alaina@ascpt.org</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Interested in learning more about the ASCPT Journal Family’s Editor-in-Training (EIT) program? Listen as current EITs Drs. Jane Knöchel and Zachary Taylor, along with former EIT and current Clinical and Translational Science Associate Editor Dr. Brian Fe]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Interested in learning more about the ASCPT Journal Family’s <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Journals/Editors-in-Training__;!!N11eV2iwtfs!tGwrEoKdtK_fagoGF3CYZ2nudcz7ujnCJzM8mFWk0u9pHkLrVF7l9DeijoABmME_xgkbOfJmsAtAhA$">Editor-in-Training (EIT) program</a>? Listen as current EITs Drs. <a href="https://urldefense.com/v3/__https:/www.linkedin.com/in/jane-kn**Achel-2a060412b/__;w7Y!!N11eV2iwtfs!tGwrEoKdtK_fagoGF3CYZ2nudcz7ujnCJzM8mFWk0u9pHkLrVF7l9DeijoABmME_xgkbOfJkeY3wgw$">Jane Knöchel</a> and <a href="https://urldefense.com/v3/__https:/www.linkedin.com/in/zltaylor16/__;!!N11eV2iwtfs!tGwrEoKdtK_fagoGF3CYZ2nudcz7ujnCJzM8mFWk0u9pHkLrVF7l9DeijoABmME_xgkbOfIPFgxL1A$">Zachary Taylor</a>, along with former EIT and current <em>Clinical and Translational Science </em>Associate Editor Dr. <a href="https://urldefense.com/v3/__https:/www.linkedin.com/in/brian-ferslew-41b6a3bb/__;!!N11eV2iwtfs!tGwrEoKdtK_fagoGF3CYZ2nudcz7ujnCJzM8mFWk0u9pHkLrVF7l9DeijoABmME_xgkbOfJdKkL-KA$">Brian Ferslew</a>, share their experiences with the program. Applications for the 6th EIT cohort are being accepted through June 20, 2024. If you have any questions about the program or applying, please contact Deputy Managing Editor Alaina Webster at <a href="mailto:alaina@ascpt.org">alaina@ascpt.org</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/333/learn-more-about-ascpts-editors-in-training-program.mp3" length="15158662" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Interested in learning more about the ASCPT Journal Family’s Editor-in-Training (EIT) program? Listen as current EITs Drs. Jane Knöchel and Zachary Taylor, along with former EIT and current Clinical and Translational Science Associate Editor Dr. Brian Ferslew, share their experiences with the program. Applications for the 6th EIT cohort are being accepted through June 20, 2024. If you have any questions about the program or applying, please contact Deputy Managing Editor Alaina Webster at alaina@ascpt.org.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Learn More About ASCPT&#8217;s Editors-in-Training Program</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>19:36</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Interested in learning more about the ASCPT Journal Family’s Editor-in-Training (EIT) program? Listen as current EITs Drs. Jane Knöchel and Zachary Taylor, along with former EIT and current Clinical and Translational Science Associate Editor Dr. Brian Ferslew, share their experiences with the program. Applications for the 6th EIT cohort are being accepted through June 20, 2024. If you have any questions about the program or applying, please contact Deputy Managing Editor Alaina Webster at alaina@ascpt.org.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Submit Your Artificial Intelligence/Machine Learning Research to CTS!</title>
	<link>https://ascptpod.com/podcast/submit-your-artificial-intelligence-machine-learning-research-to-cts/</link>
	<pubDate>Wed, 12 Jun 2024 18:20:14 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=331</guid>
	<description><![CDATA[<p><em>Clinical and Translational Science</em> (<em>CTS</em>) has launched a <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28445/CTS-Call-for-Papers-Artificial-Intelligence-Machine-Learning-AI-ML">Call for Papers</a> for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes <em>CTS</em> Associate Editors Dr. Mohamed Shahin and Dr. Qi Liu to discuss the types of submissions they’d most like to see as well as why submitting to a special collection could be a great visibility booster for your paper! The <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.ai-machine-learning">first handful of papers accepted for this collection are already available online</a>, so be sure to check them out. If you have questions about submitting for this AI/ML collection, please contact Managing Editor Alethea Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes CTS Associate Editors Dr. Mohamed Shahin]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical and Translational Science</em> (<em>CTS</em>) has launched a <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28445/CTS-Call-for-Papers-Artificial-Intelligence-Machine-Learning-AI-ML">Call for Papers</a> for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes <em>CTS</em> Associate Editors Dr. Mohamed Shahin and Dr. Qi Liu to discuss the types of submissions they’d most like to see as well as why submitting to a special collection could be a great visibility booster for your paper! The <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.ai-machine-learning">first handful of papers accepted for this collection are already available online</a>, so be sure to check them out. If you have questions about submitting for this AI/ML collection, please contact Managing Editor Alethea Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/331/submit-your-artificial-intelligence-machine-learning-research-to-cts.mp3" length="7770094" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes CTS Associate Editors Dr. Mohamed Shahin and Dr. Qi Liu to discuss the types of submissions they’d most like to see as well as why submitting to a special collection could be a great visibility booster for your paper! The first handful of papers accepted for this collection are already available online, so be sure to check them out. If you have questions about submitting for this AI/ML collection, please contact Managing Editor Alethea Gerding at alethea@ascpt.org.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Submit Your Artificial Intelligence/Machine Learning Research to CTS!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:10</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical and Translational Science (CTS) has launched a Call for Papers for its second special collection, which will focus on artificial intelligence and machine learning. Join host Alaina Webster as she welcomes CTS Associate Editors Dr. Mohamed Shahin and Dr. Qi Liu to discuss the types of submissions they’d most like to see as well as why submitting to a special collection could be a great visibility booster for your paper! The first handful of papers accepted for this collection are already available online, so be sure to check them out. If you have questions about submitting for this AI/ML collection, please contact Managing Editor Alethea Gerding at alethea@ascpt.org.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>CPT Rare Diseases Call for Papers</title>
	<link>https://ascptpod.com/podcast/cpt-rare-diseases-call-for-papers/</link>
	<pubDate>Mon, 13 May 2024 17:17:03 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=327</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> has an open call for papers on <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleID/28443__;!!N11eV2iwtfs!urg_XqOWA8t7bF2f-3d3Ns6rUNpwpouT63zpiK70hRGRBvz38u7yuiakOGW83VQAHzPjiQjEUrGYtA$">Rare and Orphan Diseases</a>, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why <em>CPT </em>chose this theme and what types of papers the editors are hoping to receive. If you have questions about submitting papers for this themed issue, please contact Managing Editor Aletha Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> has an open call for papers on <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleID/28443__;!!N11eV2iwtfs!urg_XqOWA8t7bF2f-3d3Ns6rUNpwpouT63zpiK70hRGRBvz38u7yuiakOGW83VQAHzPjiQjEUrGYtA$">Rare and Orphan Diseases</a>, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why <em>CPT </em>chose this theme and what types of papers the editors are hoping to receive. If you have questions about submitting papers for this themed issue, please contact Managing Editor Aletha Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/327/cpt-rare-diseases-call-for-papers.mp3" length="9881662" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why CPT chose this theme and what types of papers the editors are hoping to receive. If you have questions about submitting papers for this themed issue, please contact Managing Editor Aletha Gerding at alethea@ascpt.org.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>CPT Rare Diseases Call for Papers</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>12:03</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics has an open call for papers on Rare and Orphan Diseases, but the deadline is closing soon! Check out the latest episode of ClinPharmPod, where Editors-in-Training Drs. Mai Mehanna and Ya-Feng (Jay) Wen detail why CPT chose this theme and what types of papers the editors are hoping to receive. If you have questions about submitting papers for this themed issue, please contact Managing Editor Aletha Gerding at alethea@ascpt.org.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>The Story Behind the Science: CTS’s Mechanism of Action Mini Reviews</title>
	<link>https://ascptpod.com/podcast/the-story-behind-the-science-ctss-mechanism-of-action-mini-reviews/</link>
	<pubDate>Tue, 13 Feb 2024 18:09:38 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=322</guid>
	<description><![CDATA[<p>Dr. Mohamed Shahin, Associate Editor of <em>Clinical and Translational Science</em>, shares the thought process behind the newest <em>CTS</em> article type, the Mechanism of Action (MOA) Mini Review. Check out the <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.mechanism-of-action-mini-reviews">latest published MOA papers</a> or read up on <a href="https://cts.msubmit.net/cgi-bin/main.plex?form_type=display_auth_instructions">formatting specifications and submission guidelines</a> for this exciting article type. If you have questions about submitting this manuscript type, please feel free to reach out to Mohamed directly at <a href="mailto:Mohamed.Shahin@pfizer.com">Mohamed.Shahin@pfizer.com</a>, or contact ASCPT Journal Family Managing Editor Alethea Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Dr. Mohamed Shahin, Associate Editor of Clinical and Translational Science, shares the thought process behind the newest CTS article type, the Mechanism of Action (MOA) Mini Review. Check out the latest published MOA papers or read up on formatting speci]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Dr. Mohamed Shahin, Associate Editor of <em>Clinical and Translational Science</em>, shares the thought process behind the newest <em>CTS</em> article type, the Mechanism of Action (MOA) Mini Review. Check out the <a href="https://ascpt.onlinelibrary.wiley.com/doi/toc/10.1111/(ISSN)1752-8062.mechanism-of-action-mini-reviews">latest published MOA papers</a> or read up on <a href="https://cts.msubmit.net/cgi-bin/main.plex?form_type=display_auth_instructions">formatting specifications and submission guidelines</a> for this exciting article type. If you have questions about submitting this manuscript type, please feel free to reach out to Mohamed directly at <a href="mailto:Mohamed.Shahin@pfizer.com">Mohamed.Shahin@pfizer.com</a>, or contact ASCPT Journal Family Managing Editor Alethea Gerding at <a href="mailto:alethea@ascpt.org">alethea@ascpt.org</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/322/the-story-behind-the-science-ctss-mechanism-of-action-mini-reviews.mp3" length="13263238" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Mohamed Shahin, Associate Editor of Clinical and Translational Science, shares the thought process behind the newest CTS article type, the Mechanism of Action (MOA) Mini Review. Check out the latest published MOA papers or read up on formatting specifications and submission guidelines for this exciting article type. If you have questions about submitting this manuscript type, please feel free to reach out to Mohamed directly at Mohamed.Shahin@pfizer.com, or contact ASCPT Journal Family Managing Editor Alethea Gerding at alethea@ascpt.org.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>The Story Behind the Science: CTS’s Mechanism of Action Mini Reviews</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>16:05</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Dr. Mohamed Shahin, Associate Editor of Clinical and Translational Science, shares the thought process behind the newest CTS article type, the Mechanism of Action (MOA) Mini Review. Check out the latest published MOA papers or read up on formatting specifications and submission guidelines for this exciting article type. If you have questions about submitting this manuscript type, please feel free to reach out to Mohamed directly at Mohamed.Shahin@pfizer.com, or contact ASCPT Journal Family Managing Editor Alethea Gerding at alethea@ascpt.org.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>PSP Call for Papers: Pregnancy</title>
	<link>https://ascptpod.com/podcast/psp-call-for-papers-pregnancy/</link>
	<pubDate>Wed, 29 Nov 2023 14:00:53 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=316</guid>
	<description><![CDATA[<p>Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28373/PSP-Call-for-Papers-Pregnancy__;!!N11eV2iwtfs!svS4bQKu4QzN1KWU24pvMoEclz6dQLtzGp4SZWTywlkekE-tarWcOAEnqGCcpAiqi2lh_SazUz0rfQ$">Call for Papers</a> for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and systems pharmacology to improve and optimize drug therapy for pregnant and lactating women and provide a unique opportunity to exchange knowledge and scientific perspectives across the global quantitative clinical pharmacology community. Our guests for this episode expand on the relevance and importance of this theme, what types of research they’re hoping to receive, and why a global approach to highlighting this research is crucial.</p>]]></description>
	<itunes:subtitle><![CDATA[Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open Call for Papers for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open <a href="https://urldefense.com/v3/__https:/www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28373/PSP-Call-for-Papers-Pregnancy__;!!N11eV2iwtfs!svS4bQKu4QzN1KWU24pvMoEclz6dQLtzGp4SZWTywlkekE-tarWcOAEnqGCcpAiqi2lh_SazUz0rfQ$">Call for Papers</a> for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and systems pharmacology to improve and optimize drug therapy for pregnant and lactating women and provide a unique opportunity to exchange knowledge and scientific perspectives across the global quantitative clinical pharmacology community. Our guests for this episode expand on the relevance and importance of this theme, what types of research they’re hoping to receive, and why a global approach to highlighting this research is crucial.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/316/psp-call-for-papers-pregnancy.mp3" length="7437358" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open Call for Papers for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and systems pharmacology to improve and optimize drug therapy for pregnant and lactating women and provide a unique opportunity to exchange knowledge and scientific perspectives across the global quantitative clinical pharmacology community. Our guests for this episode expand on the relevance and importance of this theme, what types of research they’re hoping to receive, and why a global approach to highlighting this research is crucial.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>PSP Call for Papers: Pregnancy</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:07</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Join Drs. Karen Rowland-Yeo, Priya Jayachandran, and Brian Cicali, all members of the PSP Editorial Team, as they discuss the open Call for Papers for PSP’s 2024 themed issue. This special issue will illustrate recent applications of pharmacometrics and systems pharmacology to improve and optimize drug therapy for pregnant and lactating women and provide a unique opportunity to exchange knowledge and scientific perspectives across the global quantitative clinical pharmacology community. Our guests for this episode expand on the relevance and importance of this theme, what types of research they’re hoping to receive, and why a global approach to highlighting this research is crucial.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Continuing the Conversation: Audience Questions from ASCPT Journal Family Webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues”</title>
	<link>https://ascptpod.com/podcast/continuing-the-conversation/</link>
	<pubDate>Tue, 18 Jul 2023 11:00:31 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=307</guid>
	<description><![CDATA[<p>Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar <a href="https://www.ascpt.org/Resources/Knowledge-Center/Online-Education/ASCPT-Webinar-Library">is available open access on the ASCPT website</a>, so if you haven’t had a chance to watch it, you can do so. You can also read Drs. van Haarst’s and Paglialunga’s paper, which published in <em>Clinical Pharmacology &amp; Therapeutics</em>, <a href="Rifampin%20Drug–Drug–Interaction%20Studies:%20Reflections%20on%20the%20Nitrosamine%20Impurities%20Issue">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Induce]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar <a href="https://www.ascpt.org/Resources/Knowledge-Center/Online-Education/ASCPT-Webinar-Library">is available open access on the ASCPT website</a>, so if you haven’t had a chance to watch it, you can do so. You can also read Drs. van Haarst’s and Paglialunga’s paper, which published in <em>Clinical Pharmacology &amp; Therapeutics</em>, <a href="Rifampin%20Drug–Drug–Interaction%20Studies:%20Reflections%20on%20the%20Nitrosamine%20Impurities%20Issue">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/307/continuing-the-conversation.mp3" length="15427797" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar is available open access on the ASCPT website, so if you haven’t had a chance to watch it, you can do so. You can also read Drs. van Haarst’s and Paglialunga’s paper, which published in Clinical Pharmacology &amp; Therapeutics, here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Continuing the Conversation: Audience Questions from ASCPT Journal Family Webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues”</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>25:33</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Moderators Drs. Murugesh Kandasamy and Mayur Ladumor are joined by webinar presenters Drs. Aernout van Haarst and Sabina Paglialunga as they continue answering questions from their ASCPT Journal Family webinar “Alternatives for Rifampin as a CYP3A Inducer in DDI Studies in View of N-Nitrosamine Impurity Issues.” The webinar is available open access on the ASCPT website, so if you haven’t had a chance to watch it, you can do so. You can also read Drs. van Haarst’s and Paglialunga’s paper, which published in Clinical Pharmacology &amp; Therapeutics, here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Call for Papers: Artificial Intelligence and Machine Learning</title>
	<link>https://ascptpod.com/podcast/call-for-papers-artificial-intelligence-and-machine-learning/</link>
	<pubDate>Wed, 26 Apr 2023 13:00:47 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=294</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched a <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28091/CPT-Call-for-Papers-Artificial-Intelligence-Machine-Learning">Call for Papers</a> for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join host Alaina Webster as she welcomes <em>CPT</em>’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. Qi Liu to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join h]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched a <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28091/CPT-Call-for-Papers-Artificial-Intelligence-Machine-Learning">Call for Papers</a> for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join host Alaina Webster as she welcomes <em>CPT</em>’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. Qi Liu to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/294/call-for-papers-artificial-intelligence-and-machine-learning.mp3" length="6747981" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. Qi Liu to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Call for Papers: Artificial Intelligence and Machine Learning</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:59</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its January 2024 themed issue titled &#8220;The Application of Artificial Intelligence and Machine Learning (AI/ML) in Clinical Pharmacology and Therapeutics.&#8221; Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Amita Joshi, and Guest Editor Dr. Qi Liu to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Call for Papers: Real-World Evidence and Real-World Data</title>
	<link>https://ascptpod.com/podcast/call-for-papers-real-world-evidence-and-real-world-data/</link>
	<pubDate>Wed, 19 Apr 2023 16:48:50 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=292</guid>
	<description><![CDATA[<p>Join Editor-in-Chief Dr. John Wagner and Associate Editor <a href="mailto:p.ravenstijn@affimed.com">Dr. Paulien Ravenstijn</a> as they discuss the FIRST EVER <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28120/CTS-Call-for-Papers-Real-World-Evidence">Call for Papers</a> from <em>Clinical and Translational Science</em> (<em>CTS</em>). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the <em>CTS</em> editorial team will be considering submissions for the issue through early September of 2023. This Call was developed around the ASCPT 2023 Annual Meeting Pre-Conference “Advancing the Utilization of Real-World Data (RWD) and Real-World Evidence (RWE) in Clinical Pharmacology and Translational Research,” so if you have questions about the suitability of the topic for inclusion in the issue, please feel free to contact Paulien or pre-conference co-Chairs <a href="mailto:karen.yeo@certara.com">Dr. Karen Rowland Yeo</a> and <a href="mailto:Jing.Liu@pfizer.com">Dr. Jing Liu</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, wh]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Join Editor-in-Chief Dr. John Wagner and Associate Editor <a href="mailto:p.ravenstijn@affimed.com">Dr. Paulien Ravenstijn</a> as they discuss the FIRST EVER <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/28120/CTS-Call-for-Papers-Real-World-Evidence">Call for Papers</a> from <em>Clinical and Translational Science</em> (<em>CTS</em>). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the <em>CTS</em> editorial team will be considering submissions for the issue through early September of 2023. This Call was developed around the ASCPT 2023 Annual Meeting Pre-Conference “Advancing the Utilization of Real-World Data (RWD) and Real-World Evidence (RWE) in Clinical Pharmacology and Translational Research,” so if you have questions about the suitability of the topic for inclusion in the issue, please feel free to contact Paulien or pre-conference co-Chairs <a href="mailto:karen.yeo@certara.com">Dr. Karen Rowland Yeo</a> and <a href="mailto:Jing.Liu@pfizer.com">Dr. Jing Liu</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/292/call-for-papers-real-world-evidence-and-real-world-data.mp3" length="5891001" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the CTS editorial team will be considering submissions for the issue through early September of 2023. This Call was developed around the ASCPT 2023 Annual Meeting Pre-Conference “Advancing the Utilization of Real-World Data (RWD) and Real-World Evidence (RWE) in Clinical Pharmacology and Translational Research,” so if you have questions about the suitability of the topic for inclusion in the issue, please feel free to contact Paulien or pre-conference co-Chairs Dr. Karen Rowland Yeo and Dr. Jing Liu.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:14</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Join Editor-in-Chief Dr. John Wagner and Associate Editor Dr. Paulien Ravenstijn as they discuss the FIRST EVER Call for Papers from Clinical and Translational Science (CTS). This special collection focusing on Real-World Evidence and Real-World Data, which will be a rolling collection, will initially publish in the second half of 2023, and the CTS editorial team will be considering submissions for the issue through early September of 2023. This Call was developed around the ASCPT 2023 Annual Meeting Pre-Conference “Advancing the Utilization of Real-World Data (RWD) and Real-World Evidence (RWE) in Clinical Pharmacology and Translational Research,” so if you have questions about the suitability of the topic for inclusion in the issue, please feel free to contact Paulien or pre-conference co-Chairs Dr. Karen Rowland Yeo and Dr. Jing Liu.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Translating Clinical Pharmacology for ALL</title>
	<link>https://ascptpod.com/podcast/translating-clinical-pharmacology-for-all/</link>
	<pubDate>Mon, 20 Mar 2023 21:25:27 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=288</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> recently published its second themed issue of 2023 – <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2023/113/3">Diversity, Equity, &amp; Inclusion: Translating Clinical Pharmacology for ALL</a>. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Giacomini, Associate Editor Dr. Karthik Venkatakrishnan, and Editor-in-Training Dr. Karen Brown as they discuss where diversity, equity, and inclusion (DEI) currently stands within clinical pharmacology, ideas and tools for moving it forward, and what they hope DEI will mean for future research, patients, and researchers.</p>
<p>If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information <a href="https://www.ascpt.org/Journals/Call-for-Papers">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its second themed issue of 2023 – Diversity, Equity, &amp; Inclusion: Translating Clinical Pharmacology for ALL. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Gia]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> recently published its second themed issue of 2023 – <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2023/113/3">Diversity, Equity, &amp; Inclusion: Translating Clinical Pharmacology for ALL</a>. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Giacomini, Associate Editor Dr. Karthik Venkatakrishnan, and Editor-in-Training Dr. Karen Brown as they discuss where diversity, equity, and inclusion (DEI) currently stands within clinical pharmacology, ideas and tools for moving it forward, and what they hope DEI will mean for future research, patients, and researchers.</p>
<p>If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information <a href="https://www.ascpt.org/Journals/Call-for-Papers">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/288/translating-clinical-pharmacology-for-all.mp3" length="10233003" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its second themed issue of 2023 – Diversity, Equity, &amp; Inclusion: Translating Clinical Pharmacology for ALL. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Giacomini, Associate Editor Dr. Karthik Venkatakrishnan, and Editor-in-Training Dr. Karen Brown as they discuss where diversity, equity, and inclusion (DEI) currently stands within clinical pharmacology, ideas and tools for moving it forward, and what they hope DEI will mean for future research, patients, and researchers.
If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Translating Clinical Pharmacology for ALL</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:34</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its second themed issue of 2023 – Diversity, Equity, &amp; Inclusion: Translating Clinical Pharmacology for ALL. Join Editor-in-Chief Dr. Piet van der Graaf, Deputy Editor-in-Chief Dr. Kathy Giacomini, Associate Editor Dr. Karthik Venkatakrishnan, and Editor-in-Training Dr. Karen Brown as they discuss where diversity, equity, and inclusion (DEI) currently stands within clinical pharmacology, ideas and tools for moving it forward, and what they hope DEI will mean for future research, patients, and researchers.
If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Hesitation Does Not Equal Anti-Vaccination</title>
	<link>https://ascptpod.com/podcast/hesitation-does-not-equal-anti-vaccination/</link>
	<pubDate>Wed, 01 Feb 2023 14:00:00 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=283</guid>
	<description><![CDATA[<p>Expanding on a <a href="https://ascptpod.com/podcast/clinpharmpod-covid-19-vaccine-hesitancy-and-sociodemographics/">previous podcast</a> discussing research published in <em>Clinical and Translational Science</em>, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” individuals who were wary of the COVID-19 vaccine but did, ultimately, receive at least one dose of the vaccine. Pearl, Ramey, and Erica consider how sources of information, trust in news organizations and the government, and factors such as age, race, and ethnicity are interwoven into people’s personal decisions about whether or not to receive a COVID vaccine.</p>
<p>Your can read <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13367">Pearl</a> and <a href="The%20vaccine%20hesitancy%20continuum%20among%20hesitant%20adopters%20of%20the%20COVID-19%20vaccine">Ramey’s</a> published work in the Wiley Online Library, as well as the <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13077">paper under discussion</a> in the previous podcast linked above.</p>]]></description>
	<itunes:subtitle><![CDATA[Expanding on a previous podcast discussing research published in Clinical and Translational Science, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” indivi]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Expanding on a <a href="https://ascptpod.com/podcast/clinpharmpod-covid-19-vaccine-hesitancy-and-sociodemographics/">previous podcast</a> discussing research published in <em>Clinical and Translational Science</em>, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” individuals who were wary of the COVID-19 vaccine but did, ultimately, receive at least one dose of the vaccine. Pearl, Ramey, and Erica consider how sources of information, trust in news organizations and the government, and factors such as age, race, and ethnicity are interwoven into people’s personal decisions about whether or not to receive a COVID vaccine.</p>
<p>Your can read <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13367">Pearl</a> and <a href="The%20vaccine%20hesitancy%20continuum%20among%20hesitant%20adopters%20of%20the%20COVID-19%20vaccine">Ramey’s</a> published work in the Wiley Online Library, as well as the <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13077">paper under discussion</a> in the previous podcast linked above.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/283/hesitation-does-not-equal-anti-vaccination.mp3" length="25660545" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Expanding on a previous podcast discussing research published in Clinical and Translational Science, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” individuals who were wary of the COVID-19 vaccine but did, ultimately, receive at least one dose of the vaccine. Pearl, Ramey, and Erica consider how sources of information, trust in news organizations and the government, and factors such as age, race, and ethnicity are interwoven into people’s personal decisions about whether or not to receive a COVID vaccine.
Your can read Pearl and Ramey’s published work in the Wiley Online Library, as well as the paper under discussion in the previous podcast linked above.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>Hesitation Does Not Equal Anti-Vaccination</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>36:05</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Expanding on a previous podcast discussing research published in Clinical and Translational Science, Drs. Pearl McElfish and Ramey Moore join moderator Dr. Erica Woodahl to delve into vaccine hesitancy and people classified as “hesitant adopters,” individuals who were wary of the COVID-19 vaccine but did, ultimately, receive at least one dose of the vaccine. Pearl, Ramey, and Erica consider how sources of information, trust in news organizations and the government, and factors such as age, race, and ethnicity are interwoven into people’s personal decisions about whether or not to receive a COVID vaccine.
Your can read Pearl and Ramey’s published work in the Wiley Online Library, as well as the paper under discussion in the previous podcast linked above.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Building on Biosimilars</title>
	<link>https://ascptpod.com/podcast/building-on-biosimilars/</link>
	<pubDate>Mon, 23 Jan 2023 19:40:13 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=281</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> recently published its first themed issue of 2023 – <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2023/113/1">Innovations in Biosimilars</a>. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that interesting and somewhat playful cover.</p>
<p>If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information <a href="https://www.ascpt.org/Journals/Call-for-Papers">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoug]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> recently published its first themed issue of 2023 – <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2023/113/1">Innovations in Biosimilars</a>. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that interesting and somewhat playful cover.</p>
<p>If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information <a href="https://www.ascpt.org/Journals/Call-for-Papers">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/281/building-on-biosimilars.mp3" length="10133925" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that interesting and somewhat playful cover.
If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>Building on Biosimilars</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:51</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its first themed issue of 2023 – Innovations in Biosimilars. Join Editor-in-Chief Dr. Piet van der Graaf and Guest Editor Yow-Ming Wang as they discuss what papers stood out to them, their thoughts around the growing importance of biosimilars in Clinical Pharmacology, and how the editorial team developed that interesting and somewhat playful cover.
If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Submit Your Novel Modalities Research!</title>
	<link>https://ascptpod.com/podcast/submit-your-novel-modalities-research/</link>
	<pubDate>Mon, 12 Dec 2022 17:38:17 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=278</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched a <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/27981/CPT-Call-for-Papers-Novel-Modalities">Call for Papers</a> for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes <em>CPT</em>’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vinks, and Editor-in-Training Dr. Sofia Choi to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vink]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched a <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/27981/CPT-Call-for-Papers-Novel-Modalities">Call for Papers</a> for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes <em>CPT</em>’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vinks, and Editor-in-Training Dr. Sofia Choi to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/278/submit-your-novel-modalities-research.mp3" length="7206729" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vinks, and Editor-in-Training Dr. Sofia Choi to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>Submit Your Novel Modalities Research!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>10:09</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its September 2023 themed issue on Novel Modalities. Join host Alaina Webster as she welcomes CPT’s Editor-in-Chief Dr. Piet van der Graaf, Associate Editor Dr. Sander Vinks, and Editor-in-Training Dr. Sofia Choi to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Call for Papers: Dose Finding in Oncology</title>
	<link>https://ascptpod.com/podcast/call-for-papers-dose-finding-in-oncology/</link>
	<pubDate>Mon, 03 Oct 2022 17:40:43 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=275</guid>
	<description><![CDATA[<p>Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em> (<em>PSP</em>). This special themed issue focusing on Dose Finding in Oncology will publish in the fourth quarter of 2023, and the <em>PSP</em> editorial team will be considering submissions for the issue through May 2023.</p>]]></description>
	<itunes:subtitle><![CDATA[Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from CPT: Pharmacometrics &amp; Systems Pharmacology (PSP). This special themed issue focusing on Dose Finding in Oncology wi]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em> (<em>PSP</em>). This special themed issue focusing on Dose Finding in Oncology will publish in the fourth quarter of 2023, and the <em>PSP</em> editorial team will be considering submissions for the issue through May 2023.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/275/call-for-papers-dose-finding-in-oncology.mp3" length="4362585" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from CPT: Pharmacometrics &amp; Systems Pharmacology (PSP). This special themed issue focusing on Dose Finding in Oncology will publish in the fourth quarter of 2023, and the PSP editorial team will be considering submissions for the issue through May 2023.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Call for Papers: Dose Finding in Oncology</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>5:49</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Join Drs. Stefanie Hennig, Sriram Krishnaswami, Priya Jayachandran, and Rajat Desikan as they discuss the latest Call for Papers from CPT: Pharmacometrics &amp; Systems Pharmacology (PSP). This special themed issue focusing on Dose Finding in Oncology will publish in the fourth quarter of 2023, and the PSP editorial team will be considering submissions for the issue through May 2023.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Talking Transporters</title>
	<link>https://ascptpod.com/podcast/talking-transporters/</link>
	<pubDate>Wed, 31 Aug 2022 14:14:53 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=270</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> recently published its third themed issue of 2022 – <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2022/112/3">Transporters</a>. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporters in Clinical Pharmacology, and how the editorial team developed that eye-catching cover.</p>
<p>If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information <a href="https://www.ascpt.org/Journals/Call-for-Papers">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its third themed issue of 2022 – Transporters. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporter]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> recently published its third themed issue of 2022 – <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2022/112/3">Transporters</a>. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporters in Clinical Pharmacology, and how the editorial team developed that eye-catching cover.</p>
<p>If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information <a href="https://www.ascpt.org/Journals/Call-for-Papers">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/270/talking-transporters.mp3" length="7232505" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its third themed issue of 2022 – Transporters. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporters in Clinical Pharmacology, and how the editorial team developed that eye-catching cover.
If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>Talking Transporters</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>10:01</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its third themed issue of 2022 – Transporters. Join Deputy Editor-in-Chief Dr. Kathy Giacomini as she relays what papers caught her eye, her thoughts around the growing importance of transporters in Clinical Pharmacology, and how the editorial team developed that eye-catching cover.
If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Sharing Data to Improve Patient-Focused Outcomes</title>
	<link>https://ascptpod.com/podcast/sharing-data-to-improve-patient-focused-outcomes/</link>
	<pubDate>Tue, 26 Apr 2022 11:00:50 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=264</guid>
	<description><![CDATA[<p>Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “<a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__ascpt.onlinelibrary.wiley.com_doi_10.1002_cpt.2528&amp;d=DwMFAg&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=q7Wi2jd37BF2sXHl_WERBg&amp;m=PisyNhKcjPeXvMcNKYD3z7nllii5y2X51kqK-xSWYxM&amp;s=67CI7goJzchLGIUvKxj2gEfajHRxlk4vLtO_GGAlxaM&amp;e=">Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases</a>?”, in the <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__ascpt.onlinelibrary.wiley.com_toc_15326535_2022_111_4&amp;d=DwMFAg&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=q7Wi2jd37BF2sXHl_WERBg&amp;m=PisyNhKcjPeXvMcNKYD3z7nllii5y2X51kqK-xSWYxM&amp;s=AbdEgLDS0SNR6tEZL2mSBqjI0xWrEZOSfxZmxPml7GY&amp;e=">April Neuroscience-themed issue</a> of <em>Clinical Pharmacology &amp; Therapeutics</em>, and she ties this work into successful data sharing models and their impact on patient outcomes. Critical Path Institute has accumulated more than 300 clinical data studies across 15+ disease areas, and its repository of data currently includes information on the following neuroscience diseases: Alzheimer’s disease, Huntington’s disease, ataxias, Duchenne muscular dystrophy, Parkinson’s disease, and multiple sclerosis.</p>]]></description>
	<itunes:subtitle><![CDATA[Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “<a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__ascpt.onlinelibrary.wiley.com_doi_10.1002_cpt.2528&amp;d=DwMFAg&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=q7Wi2jd37BF2sXHl_WERBg&amp;m=PisyNhKcjPeXvMcNKYD3z7nllii5y2X51kqK-xSWYxM&amp;s=67CI7goJzchLGIUvKxj2gEfajHRxlk4vLtO_GGAlxaM&amp;e=">Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases</a>?”, in the <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__ascpt.onlinelibrary.wiley.com_toc_15326535_2022_111_4&amp;d=DwMFAg&amp;c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&amp;r=q7Wi2jd37BF2sXHl_WERBg&amp;m=PisyNhKcjPeXvMcNKYD3z7nllii5y2X51kqK-xSWYxM&amp;s=AbdEgLDS0SNR6tEZL2mSBqjI0xWrEZOSfxZmxPml7GY&amp;e=">April Neuroscience-themed issue</a> of <em>Clinical Pharmacology &amp; Therapeutics</em>, and she ties this work into successful data sharing models and their impact on patient outcomes. Critical Path Institute has accumulated more than 300 clinical data studies across 15+ disease areas, and its repository of data currently includes information on the following neuroscience diseases: Alzheimer’s disease, Huntington’s disease, ataxias, Duchenne muscular dystrophy, Parkinson’s disease, and multiple sclerosis.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/264/sharing-data-to-improve-patient-focused-outcomes.mp3" length="10792221" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?”, in the April Neuroscience-themed issue of Clinical Pharmacology &amp; Therapeutics, and she ties this work into successful data sharing models and their impact on patient outcomes. Critical Path Institute has accumulated more than 300 clinical data studies across 15+ disease areas, and its repository of data currently includes information on the following neuroscience diseases: Alzheimer’s disease, Huntington’s disease, ataxias, Duchenne muscular dystrophy, Parkinson’s disease, and multiple sclerosis.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Sharing Data to Improve Patient-Focused Outcomes</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:50</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Critical Path Institute’s Dr. Diane Stephenson joins host Alaina Webster to discuss the importance of data sharing to improve patient care, particularly in Neuroscience. Diane and her co-authors recently published a Review, “Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?”, in the April Neuroscience-themed issue of Clinical Pharmacology &amp; Therapeutics, and she ties this work into successful data sharing models and their impact on patient outcomes. Critical Path Institute has accumulated more than 300 clinical data studies across 15+ disease areas, and its repository of data currently includes information on the following neuroscience diseases: Alzheimer’s disease, Huntington’s disease, ataxias, Duchenne muscular dystrophy, Parkinson’s disease, and multiple sclerosis.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>2023 Calls for Papers</title>
	<link>https://ascptpod.com/podcast/2023-calls-for-papers/</link>
	<pubDate>Wed, 30 Mar 2022 19:44:12 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=261</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched two Calls for Papers. The January 2023 issue of the journal will focus on <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/27689/CALL-FOR-PAPERS-CPT-Innovations-in-Biosimilars-themed-issue">Biosimilars</a>, and the March 2023 issue will showcase research that highlights <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/27720/CALL-FOR-PAPERS-CPT-Diversity-Equity-Inclusion-themed-issue">Diversity, Equity, and Inclusion</a> in clinical pharmacology and translational science. <em>CPT</em> Editor-in-Chief Piet van der Graaf and Associate Editor Karthik Venkatakrishnan join host Alaina Webster to discuss types of submission they’d most like to see submitted for these themes.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched two Calls for Papers. The January 2023 issue of the journal will focus on Biosimilars, and the March 2023 issue will showcase research that highlights Diversity, Equity, and Inclusion in clinica]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched two Calls for Papers. The January 2023 issue of the journal will focus on <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/27689/CALL-FOR-PAPERS-CPT-Innovations-in-Biosimilars-themed-issue">Biosimilars</a>, and the March 2023 issue will showcase research that highlights <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/27720/CALL-FOR-PAPERS-CPT-Diversity-Equity-Inclusion-themed-issue">Diversity, Equity, and Inclusion</a> in clinical pharmacology and translational science. <em>CPT</em> Editor-in-Chief Piet van der Graaf and Associate Editor Karthik Venkatakrishnan join host Alaina Webster to discuss types of submission they’d most like to see submitted for these themes.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/261/2023-calls-for-papers.mp3" length="9066381" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched two Calls for Papers. The January 2023 issue of the journal will focus on Biosimilars, and the March 2023 issue will showcase research that highlights Diversity, Equity, and Inclusion in clinical pharmacology and translational science. CPT Editor-in-Chief Piet van der Graaf and Associate Editor Karthik Venkatakrishnan join host Alaina Webster to discuss types of submission they’d most like to see submitted for these themes.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>2023 Calls for Papers</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>12:38</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched two Calls for Papers. The January 2023 issue of the journal will focus on Biosimilars, and the March 2023 issue will showcase research that highlights Diversity, Equity, and Inclusion in clinical pharmacology and translational science. CPT Editor-in-Chief Piet van der Graaf and Associate Editor Karthik Venkatakrishnan join host Alaina Webster to discuss types of submission they’d most like to see submitted for these themes.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>What’s New in Neuroscience?</title>
	<link>https://ascptpod.com/podcast/whats-new-in-neuroscience/</link>
	<pubDate>Sat, 19 Mar 2022 16:00:47 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=257</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> recently published its second themed issue of 2022 – <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2022/111/4">Therapeutics in Neuroscience</a>. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave with readers. If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information <a href="https://www.ascpt.org/Journals/Call-for-Papers">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichm]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> recently published its second themed issue of 2022 – <a href="https://ascpt.onlinelibrary.wiley.com/toc/15326535/2022/111/4">Therapeutics in Neuroscience</a>. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave with readers. If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information <a href="https://www.ascpt.org/Journals/Call-for-Papers">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/257/whats-new-in-neuroscience.mp3" length="9743266" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave with readers. If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png</url>
		<title>What’s New in Neuroscience?</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>13:07</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave with readers. If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/ascpt-podcast-network-cover-01.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Calling All Transporter Papers!</title>
	<link>https://ascptpod.com/podcast/calling-all-transporter-papers/</link>
	<pubDate>Tue, 14 Dec 2021 12:00:29 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=250</guid>
	<description><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched a <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/27447/Call-for-Papers-Transporters">Call for Papers</a> for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes <em>CPT</em>’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Smith to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!</p>]]></description>
	<itunes:subtitle><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes CPT’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Sm]]></itunes:subtitle>
	<content:encoded><![CDATA[<p><em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) has launched a <a href="https://www.ascpt.org/Resources/ASCPT-News/View/ArticleId/27447/Call-for-Papers-Transporters">Call for Papers</a> for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes <em>CPT</em>’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Smith to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/250/calling-all-transporter-papers.mp3" length="3959673" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes CPT’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Smith to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Calling All Transporter Papers!</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>5:13</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Clinical Pharmacology &amp; Therapeutics (CPT) has launched a Call for Papers for its September 2022 themed issue on Transporters. Join host Alaina Webster as she welcomes CPT’s Deputy Managing Editor Dr. Kathy Giacomini and Editor-in-Training Dr. Max Smith to discuss types of submissions they’d most like to see as well as why submitting to a themed issue could be a great visibility booster for your paper!]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: What’s the Best Way to Organize My Review?</title>
	<link>https://ascptpod.com/podcast/peer-review-whats-the-best-way-to-organize-my-review/</link>
	<pubDate>Mon, 20 Sep 2021 14:23:17 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=245</guid>
	<description><![CDATA[<p>Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em>, delves into why he appreciates reviews that are broken up into three sections as well as why ASCPT’s journals ask for comments to the editor as well as the reviewer.</p>
<p>You can access <em>PSP</em>’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer <a href="https://psp.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for CPT: Pharmacometrics &amp; Systems Pharm]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em>, delves into why he appreciates reviews that are broken up into three sections as well as why ASCPT’s journals ask for comments to the editor as well as the reviewer.</p>
<p>You can access <em>PSP</em>’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer <a href="https://psp.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/245/peer-review-whats-the-best-way-to-organize-my-review.mp3" length="5319141" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for CPT: Pharmacometrics &amp; Systems Pharmacology, delves into why he appreciates reviews that are broken up into three sections as well as why ASCPT’s journals ask for comments to the editor as well as the reviewer.
You can access PSP’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>7:27</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Host Alaina Webster sits down with Dr. Jonathan French to discuss the best organizational practices for a review – both from an associated editor’s standpoint and from an author’s. Jonthan, an Associate Editor for CPT: Pharmacometrics &amp; Systems Pharmacology, delves into why he appreciates reviews that are broken up into three sections as well as why ASCPT’s journals ask for comments to the editor as well as the reviewer.
You can access PSP’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: After the Review</title>
	<link>https://ascptpod.com/podcast/peer-review-after-the-review/</link>
	<pubDate>Tue, 14 Sep 2021 11:00:44 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=242</guid>
	<description><![CDATA[<p>In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em> details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision on a manuscript, and how she decides is reviewers are needed for a revised manuscript.</p>
<p>You can access <em>PSP</em>’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer <a href="https://psp.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics &amp; Systems Pharmacology details]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em> details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision on a manuscript, and how she decides is reviewers are needed for a revised manuscript.</p>
<p>You can access <em>PSP</em>’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer <a href="https://psp.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/242/peer-review-after-the-review.mp3" length="8257425" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics &amp; Systems Pharmacology details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision on a manuscript, and how she decides is reviewers are needed for a revised manuscript.
You can access PSP’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Peer Review: After the Review</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:53</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[In the fourth episode in the peer review series, Dr. Stefanie Hennig joins host Alaina Webster to walk you through what editors do with a review once it’s received. Stefanie, an Associate Editor for CPT: Pharmacometrics &amp; Systems Pharmacology details her first steps upon receiving a review, how much a reviewer’s opinion influences her decision on a manuscript, and how she decides is reviewers are needed for a revised manuscript.
You can access PSP’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: What’s Not Helpful in a Review?</title>
	<link>https://ascptpod.com/podcast/peer-review-whats-not-helpful-in-a-review/</link>
	<pubDate>Tue, 14 Sep 2021 11:00:42 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=240</guid>
	<description><![CDATA[<p>ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias.</p>
<p>You can access <em>CPT</em>’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer <a href="https://cpt.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing fe]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias.</p>
<p>You can access <em>CPT</em>’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer <a href="https://cpt.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/240/peer-review-whats-not-helpful-in-a-review.mp3" length="7274445" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias.
You can access CPT’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Peer Review: What’s Not Helpful in a Review?</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:06</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias.
You can access CPT’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Pharmacogenetics and Underrepresented Populations</title>
	<link>https://ascptpod.com/podcast/pharmacogenetics-and-underrepresented-populations/</link>
	<pubDate>Wed, 08 Sep 2021 14:38:35 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=238</guid>
	<description><![CDATA[<p>Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with <em>Clinical and Translational Science</em> authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and why equitable studies for underrepresented groups is vital to the future of clinical pharmacology and translational science.</p>
<p>You can access Tiana and Jacob’s fully Open Access paper <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13110">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with <em>Clinical and Translational Science</em> authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and why equitable studies for underrepresented groups is vital to the future of clinical pharmacology and translational science.</p>
<p>You can access Tiana and Jacob’s fully Open Access paper <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13110">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/238/pharmacogenetics-and-underrepresented-populations.mp3" length="15058725" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and why equitable studies for underrepresented groups is vital to the future of clinical pharmacology and translational science.
You can access Tiana and Jacob’s fully Open Access paper here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Pharmacogenetics and Underrepresented Populations</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>20:26</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and why equitable studies for underrepresented groups is vital to the future of clinical pharmacology and translational science.
You can access Tiana and Jacob’s fully Open Access paper here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: What’s Most Important in a Review?</title>
	<link>https://ascptpod.com/podcast/peer-review-whats-most-important-in-a-review/</link>
	<pubDate>Tue, 27 Jul 2021 09:01:38 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=235</guid>
	<description><![CDATA[<p>In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of <em>Clinical and Translational Science</em> (<em>CTS</em>). They break down the top three things Deanna looks for when undertaking a peer review as well as the importance of peer review to sound science.</p>
<p>You can access <em>CTS</em>’s Reviewer Instructions <a href="https://cts.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of <em>Clinical and Translational Science</em> (<em>CTS</em>). They break down the top three things Deanna looks for when undertaking a peer review as well as the importance of peer review to sound science.</p>
<p>You can access <em>CTS</em>’s Reviewer Instructions <a href="https://cts.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/235/peer-review-whats-most-important-in-a-review.mp3" length="7146285" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of Clinical and Translational Science (CTS). They break down the top three things Deanna looks for when undertaking a peer review as well as the importance of peer review to sound science.
You can access CTS’s Reviewer Instructions here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Peer Review: What’s Most Important in a Review?</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:57</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of Clinical and Translational Science (CTS). They break down the top three things Deanna looks for when undertaking a peer review as well as the importance of peer review to sound science.
You can access CTS’s Reviewer Instructions here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Peer Review: Should You Review This Submission?</title>
	<link>https://ascptpod.com/podcast/peer-review-should-you-review-this-submission/</link>
	<pubDate>Tue, 27 Jul 2021 09:00:22 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=232</guid>
	<description><![CDATA[<p>Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for <em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers.</p>
<p>You can access <em>CPT</em>’s Reviewer Instructions <a href="https://cpt.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology &amp; Therapeutics (CPT) about t]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for <em>Clinical Pharmacology &amp; Therapeutics</em> (<em>CPT</em>) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers.</p>
<p>You can access <em>CPT</em>’s Reviewer Instructions <a href="https://cpt.msubmit.net/cgi-bin/main.plex?form_type=display_rev_instructions">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/232/peer-review-should-you-review-this-submission.mp3" length="4735941" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology &amp; Therapeutics (CPT) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers.
You can access CPT’s Reviewer Instructions here.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>Peer Review: Should You Review This Submission?</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>5:59</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology &amp; Therapeutics (CPT) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers.
You can access CPT’s Reviewer Instructions here.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>ClinPharmPod: COVID-19 Vaccine Hesitancy and Sociodemographics</title>
	<link>https://ascptpod.com/podcast/clinpharmpod-covid-19-vaccine-hesitancy-and-sociodemographics/</link>
	<pubDate>Fri, 09 Jul 2021 14:47:52 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=229</guid>
	<description><![CDATA[<p>For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for <em>Clinical and Translational Science</em> (<em>CTS</em>). They discuss Don and his colleagues’ recent publication in <em>CTS</em>, “<a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13077">COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear</a>,” digging into how location, race, past racism, and current systemic racism factor into the willingness to receive a COVID-19 vaccination.</p>]]></description>
	<itunes:subtitle><![CDATA[For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for <em>Clinical and Translational Science</em> (<em>CTS</em>). They discuss Don and his colleagues’ recent publication in <em>CTS</em>, “<a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13077">COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear</a>,” digging into how location, race, past racism, and current systemic racism factor into the willingness to receive a COVID-19 vaccination.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/229/clinpharmpod-covid-19-vaccine-hesitancy-and-sociodemographics.mp3" length="14938149" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for Clinical and Translational Science (CTS). They discuss Don and his colleagues’ recent publication in CTS, “COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear,” digging into how location, race, past racism, and current systemic racism factor into the willingness to receive a COVID-19 vaccination.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png</url>
		<title>ClinPharmPod: COVID-19 Vaccine Hesitancy and Sociodemographics</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>19:18</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for Clinical and Translational Science (CTS). They discuss Don and his colleagues’ recent publication in CTS, “COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear,” digging into how location, race, past racism, and current systemic racism factor into the willingness to receive a COVID-19 vaccination.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/social-sharing-default.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>PSPod: Journal Submissions in the Time of COVID</title>
	<link>https://ascptpod.com/podcast/pspod-journal-submissions-in-the-time-of-covid/</link>
	<pubDate>Wed, 30 Sep 2020 13:35:53 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=225</guid>
	<description><![CDATA[<p>On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em>, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of <em>Clinical and Translational Science</em>, and Shirley K. Seo, PhD, Associate Editor of <em>Clinical Pharmacology &amp; Therapeutics</em>, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.</p>]]></description>
	<itunes:subtitle><![CDATA[On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &amp; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em>, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of <em>Clinical and Translational Science</em>, and Shirley K. Seo, PhD, Associate Editor of <em>Clinical Pharmacology &amp; Therapeutics</em>, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/225/pspod-journal-submissions-in-the-time-of-covid.mp3" length="100566" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &amp; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &amp; Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/pspod-cover.png"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/pspod-cover.png</url>
		<title>PSPod: Journal Submissions in the Time of COVID</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>17:28</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &amp; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &amp; Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/pspod-cover.png"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>ClinPharmPod: Journal Submissions in the Time of COVID</title>
	<link>https://ascptpod.com/podcast/clinpharmpod-journal-submissions-in-the-time-of-covid/</link>
	<pubDate>Wed, 30 Sep 2020 13:34:23 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">https://ascptpod.com/?post_type=podcast&#038;p=221</guid>
	<description><![CDATA[<p>On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em>, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of <em>Clinical and Translational Science</em>, and Shirley K. Seo, PhD, Associate Editor of <em>Clinical Pharmacology &amp; Therapeutics</em>, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.</p>]]></description>
	<itunes:subtitle><![CDATA[On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &amp; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and S]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of <em>CPT: Pharmacometrics &amp; Systems Pharmacology</em>, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of <em>Clinical and Translational Science</em>, and Shirley K. Seo, PhD, Associate Editor of <em>Clinical Pharmacology &amp; Therapeutics</em>, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/221/clinpharmpod-journal-submissions-in-the-time-of-covid.mp3" length="90068" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &amp; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &amp; Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.]]></itunes:summary>
	<itunes:image href="https://ascptpod.com/wp-content/uploads/2020/03/clinpharmpod-cover-image.jpg"></itunes:image>
	<image>
		<url>https://ascptpod.com/wp-content/uploads/2020/03/clinpharmpod-cover-image.jpg</url>
		<title>ClinPharmPod: Journal Submissions in the Time of COVID</title>
	</image>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>17:13</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics &amp; Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology &amp; Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.]]></googleplay:description>
	<googleplay:image href="https://ascptpod.com/wp-content/uploads/2020/03/clinpharmpod-cover-image.jpg"></googleplay:image>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development</title>
	<link>https://ascptpod.com/podcast/midd_part_2/</link>
	<pubDate>Mon, 13 May 2019 14:29:40 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=200</guid>
	<description><![CDATA[<p>On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development” which published in the January 2019 issue of PSP. <a href="https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/psp4.12379">The article is available here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development” which published in the January 2019 issue of PSP. <a href="https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/psp4.12379">The article is available here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/200/midd_part_2.mp3" length="13879959" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:34</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>PDUFA VI: It Is Time to Unleash the Full Potential  of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck</title>
	<link>https://ascptpod.com/podcast/pdufa-vi-it-is-time-to-unleash-the-full-potential-of-model-informed-drug-development/</link>
	<pubDate>Mon, 29 Apr 2019 19:46:38 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=197</guid>
	<description><![CDATA[<p>On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It&#8217;s Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. <a href="https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/psp4.12365">The article is available here.</a></p>]]></description>
	<itunes:subtitle><![CDATA[On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspec]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It&#8217;s Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. <a href="https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/psp4.12365">The article is available here.</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/197/pdufa-vi-it-is-time-to-unleash-the-full-potential-of-model-informed-drug-development.mp3" length="23693198" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It&#8217;s Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>19:45</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It&#8217;s Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Mathematical Biology Models of Parkinson’s Disease with guests Piet van der Graaf, Suruchi Bakshi, and Chao Chen</title>
	<link>https://ascptpod.com/podcast/mathematical-biology-models-parkinsons-disease-guests-piet-van-der-graaf-suruchi-bakshi-chao-chen/</link>
	<pubDate>Thu, 28 Mar 2019 19:50:58 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=193</guid>
	<description><![CDATA[<p>On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &amp; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published in the February 2019 issue of PSP, which is available <a href="https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/psp4.12362">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &amp; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) mode]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &amp; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published in the February 2019 issue of PSP, which is available <a href="https://ascpt.onlinelibrary.wiley.com/doi/epdf/10.1002/psp4.12362">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/193/mathematical-biology-models-parkinsons-disease-guests-piet-van-der-graaf-suruchi-bakshi-chao-chen.mp3" length="14404015" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &amp; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published in the February 2019 issue of PSP, which is available here.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>12:00</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling &amp; Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published in the February 2019 issue of PSP, which is available here.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Quantitative Systems Toxicology Modeling with guest Dr. Paul Watkins</title>
	<link>https://ascptpod.com/podcast/quantitative-systems-toxicology-modeling-guest-dr-paul-watkins/</link>
	<pubDate>Thu, 30 Aug 2018 16:01:05 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=188</guid>
	<description><![CDATA[<p>On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, discusses quantitative systems toxicology (QST) and quantitative systems pharmacology (QSP) modeling, recent examples of their application, and how they might better inform decision-making in the pharma industry. Dr. Watkins recently wrote a Commentary in <em>PSP</em> related to this topic and it is available <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1002/psp4.12303">here</a>.</p>]]></description>
	<itunes:subtitle><![CDATA[On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, disc]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, discusses quantitative systems toxicology (QST) and quantitative systems pharmacology (QSP) modeling, recent examples of their application, and how they might better inform decision-making in the pharma industry. Dr. Watkins recently wrote a Commentary in <em>PSP</em> related to this topic and it is available <a href="https://ascpt.onlinelibrary.wiley.com/doi/10.1002/psp4.12303">here</a>.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/188/quantitative-systems-toxicology-modeling-guest-dr-paul-watkins.mp3" length="13967732" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, discusses quantitative systems toxicology (QST) and quantitative systems pharmacology (QSP) modeling, recent examples of their application, and how they might better inform decision-making in the pharma industry. Dr. Watkins recently wrote a Commentary in PSP related to this topic and it is available here.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>11:38</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[On today’s episode, Dr. Paul Watkins, the Howard Q. Ferguson Distinguished Professor at Eshelman School of Pharmacy, University of North Carolina at Chapel Hill and the Director of the University of North Carolina Institute for Drug Safety Sciences, discusses quantitative systems toxicology (QST) and quantitative systems pharmacology (QSP) modeling, recent examples of their application, and how they might better inform decision-making in the pharma industry. Dr. Watkins recently wrote a Commentary in PSP related to this topic and it is available here.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Reverse Translation Special Joint Episode</title>
	<link>https://ascptpod.com/podcast/reverse-translation-special-joint-episode/</link>
	<pubDate>Thu, 08 Mar 2018 02:37:32 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=184</guid>
	<description><![CDATA[<p>On this special joint episode of ClinPharmPod, the official podcast for <em>Clinical Pharmacology and Therapeutics</em>, and PSPod, the official podcast of <em>CPT: Pharmacometrics and Systems Pharmacology</em> Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for <em>Clinical Pharmacology and Therapeutics</em>, Lang Li, from the Ohio State University and Associate Editor for <em>CPT: Pharmacometrics and Systems Pharmacology</em>, and Valentina Shakhnovich from Children’s Mercy Hospital in Kansas City and Associate Editor for <em>Clinical and Translational Science </em>discuss reverse translation, the theme of a joint issue of articles recently published in the ASCPT journal family. They discuss the concept of reverse translation as a means to maximize the value of the ever-growing reservoir of real-world data in order to more effectively drive future research using retrospective analysis. <a href="http://ascpt.onlinelibrary.wiley.com/hub/ascpt_reverse_translation_issue.html">Please visit the full joint virtual issue by clicking here.</a></p>]]></description>
	<itunes:subtitle><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Assoc]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>On this special joint episode of ClinPharmPod, the official podcast for <em>Clinical Pharmacology and Therapeutics</em>, and PSPod, the official podcast of <em>CPT: Pharmacometrics and Systems Pharmacology</em> Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for <em>Clinical Pharmacology and Therapeutics</em>, Lang Li, from the Ohio State University and Associate Editor for <em>CPT: Pharmacometrics and Systems Pharmacology</em>, and Valentina Shakhnovich from Children’s Mercy Hospital in Kansas City and Associate Editor for <em>Clinical and Translational Science </em>discuss reverse translation, the theme of a joint issue of articles recently published in the ASCPT journal family. They discuss the concept of reverse translation as a means to maximize the value of the ever-growing reservoir of real-world data in order to more effectively drive future research using retrospective analysis. <a href="http://ascpt.onlinelibrary.wiley.com/hub/ascpt_reverse_translation_issue.html">Please visit the full joint virtual issue by clicking here.</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/184/reverse-translation-special-joint-episode.mp3" length="22324853" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and Valentina Shakhnovich from Children’s Mercy Hospital in Kansas City and Associate Editor for Clinical and Translational Science discuss reverse translation, the theme of a joint issue of articles recently published in the ASCPT journal family. They discuss the concept of reverse translation as a means to maximize the value of the ever-growing reservoir of real-world data in order to more effectively drive future research using retrospective analysis. Please visit the full joint virtual issue by clicking here.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>18:36</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[On this special joint episode of ClinPharmPod, the official podcast for Clinical Pharmacology and Therapeutics, and PSPod, the official podcast of CPT: Pharmacometrics and Systems Pharmacology Karthik Venkatakrishnan from Takeda Pharmaceuticals and Associate Editor for Clinical Pharmacology and Therapeutics, Lang Li, from the Ohio State University and Associate Editor for CPT: Pharmacometrics and Systems Pharmacology, and Valentina Shakhnovich from Children’s Mercy Hospital in Kansas City and Associate Editor for Clinical and Translational Science discuss reverse translation, the theme of a joint issue of articles recently published in the ASCPT journal family. They discuss the concept of reverse translation as a means to maximize the value of the ever-growing reservoir of real-world data in order to more effectively drive future research using retrospective analysis. Please visit the full joint virtual issue by clicking here.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Stuart MacLeod on Improving Medicine Use for Children</title>
	<link>https://ascptpod.com/podcast/stuart-macleod-improving-medicine-use-children/</link>
	<pubDate>Tue, 14 Nov 2017 14:34:36 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=161</guid>
	<description><![CDATA[<p>In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under 14 years of age reside. You can read more in the <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/cpt.v101.2/">June 2017 issue of CPT </a>focused on Drugs for Chirldren.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under 14 years of age reside. You can read more in the <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/cpt.v101.2/">June 2017 issue of CPT </a>focused on Drugs for Chirldren.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/161/stuart-macleod-improving-medicine-use-children.mp3" length="27213908" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under 14 years of age reside. You can read more in the June 2017 issue of CPT focused on Drugs for Chirldren.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>22:41</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[In this episode Dennis Velasco speaks with Stuart MacLeod from the University of British Columbia about efforts to equip pediatric clinical pharmacologists and clinical pharmacists with the necessary skills in relevant research and educational methods to address a shortfall in the human resource pool, particularly in low- and lower-middle-income countries where a majority of children under 14 years of age reside. You can read more in the June 2017 issue of CPT focused on Drugs for Chirldren.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>&#8220;Thoughtflow&#8221; with guests Mike Smith, Justin Wilkins, and Amy Cheung</title>
	<link>https://ascptpod.com/podcast/thoughtflow-guests-mike-smith-justin-wilkins-amy-cheung/</link>
	<pubDate>Sat, 11 Nov 2017 02:10:41 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=179</guid>
	<description><![CDATA[<p>On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.</p>]]></description>
	<itunes:subtitle><![CDATA[On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.</p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/179/thoughtflow-guests-mike-smith-justin-wilkins-amy-cheung.mp3" length="21180665" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>17:39</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[On today’s episode, Mike Smith from Pfizer, Justin Wilkins from Occams, and Amy Cheung from AstraZeneca discuss “Thoughtflow”, a set of standards compiled by the DDMoRe consortium to help facilitate the capture, storage, and reporting of knowledge in the context of MID3, as well as to support reproducibility.]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Pharmacometrics for Immuno-oncology with guest Iñaki F. Trocóniz</title>
	<link>https://ascptpod.com/podcast/pharmacometrics-immuno-oncology-guest-inaki-f-troconiz/</link>
	<pubDate>Wed, 19 Jul 2017 15:22:14 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=133</guid>
	<description><![CDATA[<p>This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.50/full" target="_blank" rel="noopener noreferrer">here</a>. Also, please find additional CPT:PSP articles related to this topic in the Immuno-oncology Virtual Issue, which is available <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/(ISSN)2163-8306.Immunooncology/" target="_blank" rel="noopener noreferrer">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue here. Also, please find additional CPT:PSP articles]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.50/full" target="_blank" rel="noopener noreferrer">here</a>. Also, please find additional CPT:PSP articles related to this topic in the Immuno-oncology Virtual Issue, which is available <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/(ISSN)2163-8306.Immunooncology/" target="_blank" rel="noopener noreferrer">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/133/pharmacometrics-immuno-oncology-guest-inaki-f-troconiz.mp3" length="9766697" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue here. Also, please find additional CPT:PSP articles related to this topic in the Immuno-oncology Virtual Issue, which is available here.
Listen and subscribe for free on iTunes]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:08</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Dr. Iñaki F. Trocóniz discussing how pharmacometric techniques can be used to counteract immuno-response suppression by tumor cells. Read his commentary from the January 2017 issue here. Also, please find additional CPT:PSP articles related to this topic in the Immuno-oncology Virtual Issue, which is available here.
Listen and subscribe for free on iTunes]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Marilyn Huestis on Designer Drugs</title>
	<link>https://ascptpod.com/podcast/marilyn-huestis-on-designer-drugs/</link>
	<pubDate>Fri, 21 Apr 2017 14:57:07 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=91</guid>
	<description><![CDATA[<p>In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/cpt.v101.2/">February issue of CPT </a>focused on Designer Drugs.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how the]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/cpt.v101.2/">February issue of CPT </a>focused on Designer Drugs.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/91/marilyn-huestis-on-designer-drugs.mp3" length="16192302" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer Drugs.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>13:30</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[In this episode Dennis Velasco speaks with Marilyn Huestis from the University of Maryland School of Medicine about novel psychoactive substances (e.g., modafinil, psilocybin, lysergic acid diethylamide, and 3,4-methylenedioxymethamphetamine) and how they simultaneously offer new pharmacotherapies and pose serious health problems. You can read more in the February issue of CPT focused on Designer Drugs.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Marlene Haffner on Orphan Drugs</title>
	<link>https://ascptpod.com/podcast/marlene-haffner-orphan-drugs/</link>
	<pubDate>Tue, 29 Nov 2016 01:45:08 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=103</guid>
	<description><![CDATA[<p>This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue <a href="http://onlinelibrary.wiley.com/doi/10.1002/cpt.426/abstract">here.</a></p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here.
Listen and subscribe for free on iTunes and Goog]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue <a href="http://onlinelibrary.wiley.com/doi/10.1002/cpt.426/abstract">here.</a></p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/103/marlene-haffner-orphan-drugs.mp3" length="23795502" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>19:50</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Models of Blood Coagulation with guest Satyaprakash Nayak</title>
	<link>https://ascptpod.com/podcast/episode-4-models-blood-coagulation-guest-satyaprakash-nayak/</link>
	<pubDate>Fri, 04 Nov 2016 18:44:16 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=78</guid>
	<description><![CDATA[<p>This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.50/full">here</a>. Also, please find additional <em>CPT:PSP</em> articles related to hematology in the Hematology Virtual Issue, which is available <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/(ISSN)2163-8306(CAT)VirtualIssues(VI)Hematology/">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.50/full">here</a>. Also, please find additional <em>CPT:PSP</em> articles related to hematology in the Hematology Virtual Issue, which is available <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/(ISSN)2163-8306(CAT)VirtualIssues(VI)Hematology/">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/78/episode-4-models-blood-coagulation-guest-satyaprakash-nayak.mp3" length="49662029" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to hematology in the Hematology Virtual Issue, which is available here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>20:39</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Dr. Satyaprakash Nayak discussing application of advanced pharmacometrics and quantitative systems pharmacology in hematology. Read his article from the July 2016 issue here. Also, please find additional CPT:PSP articles related to hematology in the Hematology Virtual Issue, which is available here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Bernard Vrijens on Dose Individualization</title>
	<link>https://ascptpod.com/podcast/episode-4-guest-bernard-vrijens/</link>
	<pubDate>Fri, 10 Jun 2016 18:20:19 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=70</guid>
	<description><![CDATA[<p>This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue <a href="http://onlinelibrary.wiley.com/doi/10.1002/cpt.304/abstract">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here.
Listen and subscribe for free on iTunes and Googl]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue <a href="http://onlinelibrary.wiley.com/doi/10.1002/cpt.304/abstract">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/70/episode-4-guest-bernard-vrijens.mp3" length="17770853" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>7:21</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Bernard Vrijens of WestRock Healthcare discussing quantifying the influence of adherence and dose individualization. Read his Commentary which published in the April 2016 issue here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Good Practices in Model-Informed Drug Discovery and Development with guests Scott Marshall, Sandra Visser, and Amy Cheung</title>
	<link>https://ascptpod.com/podcast/good-practices-model-informed-drug-discovery-development-guests-scott-marshall-sandra-visser-amy-cheung/</link>
	<pubDate>Mon, 09 May 2016 20:00:15 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=107</guid>
	<description><![CDATA[<p>In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.12049/full">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.12049/full">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/107/good-practices-model-informed-drug-discovery-development-guests-scott-marshall-sandra-visser-amy-cheung.mp3" length="33003659" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>27:30</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[In this episode, Drs. Scott Marshall from Pfizer, Sandra Visser from Merck, and Amy Cheung from AstraZeneca discuss &#8220;Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation&#8221;: their White Paper published in the March 2016 issue of PSP. You can get free access the White Paper by clicking here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Daniel Hertz on Pharmacogenetics</title>
	<link>https://ascptpod.com/podcast/episode-1-pharmacogenetics-guest-dr-daniel-hertz/</link>
	<pubDate>Thu, 21 Apr 2016 18:17:06 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=67</guid>
	<description><![CDATA[<p>This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine <a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cpt.294" target="_blank" rel="noopener noreferrer">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes </a>and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine here.
Liste]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine <a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cpt.294" target="_blank" rel="noopener noreferrer">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes </a>and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/67/episode-1-pharmacogenetics-guest-dr-daniel-hertz.mp3" length="47673115" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>24:46</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Daniel Hertz of the University of Michigan College of Pharmacy discussing pharmacogenetics and its potential role in screening and treating patients. Read his commentary from the February 2016 issue on Precision Medicine here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Communicating Systems Pharmacology and Pharmacometrics Models with guest Peter Bonate</title>
	<link>https://ascptpod.com/podcast/communicating-systems-pharmacology-pharmacometrics-models-guest-peter-bonate/</link>
	<pubDate>Fri, 26 Feb 2016 19:47:55 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=75</guid>
	<description><![CDATA[<p>In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen Leinfuss in the May 2015 issue, by clicking <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.37/epdf">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen L]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen Leinfuss in the May 2015 issue, by clicking <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.37/epdf">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/75/communicating-systems-pharmacology-pharmacometrics-models-guest-peter-bonate.mp3" length="42729131" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen Leinfuss in the May 2015 issue, by clicking here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>17:46</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[In this episode, Peter Bonate from Astellas, discusses effective communication in systems pharmacology and pharmacometric models. You can read a review of Dr. Bonate&#8217;s book Be a Model Communicator and Sell Your Models to Anyone, reviewed by Ellen Leinfuss in the May 2015 issue, by clicking here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Existing Practice to Modeling Approaches with guests Sandra Visser and Anne Chain</title>
	<link>https://ascptpod.com/podcast/existing-practice-modeling-approaches-guests-sandra-visser-anne-chain/</link>
	<pubDate>Fri, 15 Jan 2016 19:45:39 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=77</guid>
	<description><![CDATA[<p>This episode features Sandra Visser and Anne Chain from Merck &amp; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs. You can read Dr. Visser&#8217;s Review &#8220;Implementation of Quantitative and Systems Pharmacology in Large Pharma&#8221; by clicking <a href="http://onlinelibrary.wiley.com/doi/10.1038/psp.2014.40/full">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Sandra Visser and Anne Chain from Merck &amp; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Sandra Visser and Anne Chain from Merck &amp; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs. You can read Dr. Visser&#8217;s Review &#8220;Implementation of Quantitative and Systems Pharmacology in Large Pharma&#8221; by clicking <a href="http://onlinelibrary.wiley.com/doi/10.1038/psp.2014.40/full">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/77/existing-practice-modeling-approaches-guests-sandra-visser-anne-chain.mp3" length="49662029" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Sandra Visser and Anne Chain from Merck &amp; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs. You can read Dr. Visser&#8217;s Review &#8220;Implementation of Quantitative and Systems Pharmacology in Large Pharma&#8221; by clicking here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>20:39</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Sandra Visser and Anne Chain from Merck &amp; Co/MSD, discussing existing practice and modeling approaches and some thoughts with regard to future directions for modeling to assess and predict cardiovascular liabilities of new drugs. You can read Dr. Visser&#8217;s Review &#8220;Implementation of Quantitative and Systems Pharmacology in Large Pharma&#8221; by clicking here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Aaron Kesselheim on the 21st Century Cures Act</title>
	<link>https://ascptpod.com/podcast/episode-2-21st-century-cures-act-guest-dr-aaron-kesselheim/</link>
	<pubDate>Tue, 01 Dec 2015 19:18:03 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=68</guid>
	<description><![CDATA[<p>This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT <a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cpt.208">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT here.
Listen and subscribe for free on iTunes and Go]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT <a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cpt.208">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/68/episode-2-21st-century-cures-act-guest-dr-aaron-kesselheim.mp3" length="34620877" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:23</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Aaron S. Kesselheim of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital discussing the 21st Century Cures Act. Read his commentary in CPT here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Drug Disease Resources Consortium with guest Lutz Harnisch</title>
	<link>https://ascptpod.com/podcast/drug-disease-resources-consortium-guest-lutz-harnisch/</link>
	<pubDate>Fri, 18 Sep 2015 18:46:41 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=76</guid>
	<description><![CDATA[<p>This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found <a href="http://onlinelibrary.wiley.com/doi/10.1038/psp.2013.10/full">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found h]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found <a href="http://onlinelibrary.wiley.com/doi/10.1038/psp.2013.10/full">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/76/drug-disease-resources-consortium-guest-lutz-harnisch.mp3" length="34889262" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:30</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Lutz Harnisch from Clinical Pharmacology Pharmacometrics at Pfizer, discussing the Drug Disease Model Resources (DDMoRe) consortium. His Perspective article that introduces the activities of the DDMoRe consortium can also be found here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Michelle Roth-Cline on Microdosing Studies in Children</title>
	<link>https://ascptpod.com/podcast/episode-3-microdosing-studies-children-dr-michelle-roth-cline/</link>
	<pubDate>Tue, 15 Sep 2015 18:19:10 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=69</guid>
	<description><![CDATA[<p>This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 issue of CPT. Read the commentary <a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cpt.165">here.</a></p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 ]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 issue of CPT. Read the commentary <a href="http://onlinelibrary.wiley.com/enhanced/doi/10.1002/cpt.165">here.</a></p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/69/episode-3-microdosing-studies-children-dr-michelle-roth-cline.mp3" length="22752926" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 issue of CPT. Read the commentary here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>9:26</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Michelle Roth-Cline, ‎Pediatric Ethicist in the Office of Pediatric Therapeutics at the FDA, discussing her Commentary &#8220;Microdosing Studies in Children: A US Regulatory Perspective&#8221; which published in the September 2016 issue of CPT. Read the commentary here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Mark Ware on Medical Education on Cannabis and Cannabinoids</title>
	<link>https://ascptpod.com/podcast/mark-ware-medical-education-cannabis-cannabinoids/</link>
	<pubDate>Sat, 20 Jun 2015 03:44:23 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://clinpharmpod.com/?post_type=podcast&#038;p=97</guid>
	<description><![CDATA[<p>This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article <a href="http://onlinelibrary.wiley.com/doi/10.1002/cpt.103/abstract">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article <a href="http://onlinelibrary.wiley.com/doi/10.1002/cpt.103/abstract">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/clinpharmpod/id1209085142" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/97/mark-ware-medical-education-cannabis-cannabinoids.mp3" length="17545442" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>14:37</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[This episode features Mark A. Ware of McGill University discussing perspectives, challenges, and opportunities related to medical education on cannabis and cannabinoids. Read the article here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Databases as Tools in Pharmacometrics and Systems Pharmacology with guest Shiew-Mei Huang</title>
	<link>https://ascptpod.com/podcast/databases-as-tools-in-pharmacometrics-and-systems-pharmacology/</link>
	<pubDate>Mon, 01 Jun 2015 20:00:33 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=105</guid>
	<description><![CDATA[<p>In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of renal or hepatic impairment in a pharmacologic inhibition on the systemic exposure of drugs. Read the article <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.55/pdf">here</a>. An Editorial describing the new Database article type can also be found <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.12004/pdf">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of r]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of renal or hepatic impairment in a pharmacologic inhibition on the systemic exposure of drugs. Read the article <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.55/pdf">here</a>. An Editorial describing the new Database article type can also be found <a href="http://onlinelibrary.wiley.com/doi/10.1002/psp4.12004/pdf">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/105/databases-as-tools-in-pharmacometrics-and-systems-pharmacology.mp3" length="8381681" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of renal or hepatic impairment in a pharmacologic inhibition on the systemic exposure of drugs. Read the article here. An Editorial describing the new Database article type can also be found here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>6:59</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[In this episode, we interview Dr. Shiew-Mei Huang, Deputy Director, Office of Clinical Pharmacology, Center for Drug Evaluation and Research at the Food and Drug Administration about a drug interaction database&#8211;a tool for evaluating the impact of renal or hepatic impairment in a pharmacologic inhibition on the systemic exposure of drugs. Read the article here. An Editorial describing the new Database article type can also be found here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>

<item>
	<title>Infectious Diseases and the Role of Pharmacometrics with guest Steven E. Kern</title>
	<link>https://ascptpod.com/podcast/infectious-diseases-role-pharmacometrics-guest-steven-e-kern/</link>
	<pubDate>Mon, 02 Mar 2015 21:00:09 +0000</pubDate>
	<dc:creator><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></dc:creator>
	<guid isPermaLink="false">http://cptpspodcast.com/?post_type=podcast&#038;p=106</guid>
	<description><![CDATA[<p>In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to improve treatments in the area. You can view PSP&#8217;s Infectious Diseases virtual issue online to view the most recently published articles related to this field by clicking <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/(ISSN)2163-8306(CAT)VirtualIssues(VI)InfectiousDiseases/">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></description>
	<itunes:subtitle><![CDATA[In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to i]]></itunes:subtitle>
	<content:encoded><![CDATA[<p>In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to improve treatments in the area. You can view PSP&#8217;s Infectious Diseases virtual issue online to view the most recently published articles related to this field by clicking <a href="http://ascpt.onlinelibrary.wiley.com/hub/issue/10.1002/(ISSN)2163-8306(CAT)VirtualIssues(VI)InfectiousDiseases/">here</a>.</p>
<p>Listen and subscribe for free on <a href="https://itunes.apple.com/us/podcast/pspod/id1209086252?mt=2" target="_blank" rel="noopener noreferrer">iTunes</a> and <a href="https://play.google.com/music/listen?authuser" target="_blank" rel="noopener noreferrer">Google Play</a></p>]]></content:encoded>
	<enclosure url="https://ascptpod.com/podcast-download/106/infectious-diseases-role-pharmacometrics-guest-steven-e-kern.mp3" length="9690937" type="audio/mpeg"></enclosure>
	<itunes:summary><![CDATA[In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to improve treatments in the area. You can view PSP&#8217;s Infectious Diseases virtual issue online to view the most recently published articles related to this field by clicking here.
Listen and subscribe for free on iTunes and Google Play]]></itunes:summary>
	<itunes:explicit>false</itunes:explicit>
	<itunes:block>no</itunes:block>
	<itunes:duration>8:04</itunes:duration>
	<itunes:author><![CDATA[American Society for Clinical Pharmacology and Therapeutics]]></itunes:author>	<googleplay:description><![CDATA[In this episode, we interview Dr. Steven E. Kern, Deputy Director of Quantitative Sciences at the Bill and Melinda Gates Foundation, about infectious diseases in context of the possibilities for pharmacometrics and systems pharmacology to contribute to improve treatments in the area. You can view PSP&#8217;s Infectious Diseases virtual issue online to view the most recently published articles related to this field by clicking here.
Listen and subscribe for free on iTunes and Google Play]]></googleplay:description>
	<googleplay:explicit>No</googleplay:explicit>
	<googleplay:block>no</googleplay:block>
</item>
	</channel>
</rss>
